Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40758310	s-he4	pmol/l (pmol/l)	7588	10501	0.00%
40758310	p-he4	pmol/l (pmol/l)	1864	2505	0.12%
40758310	s-he4	— (—)	377	420	100.00%	Distribution not available
40758310	s-he4	pmol/l____ (pmol/l)	353	641	0.00%
40758310	he4proteiini,seerumista	pmol/l (pmol/l)	56	78	0.00%
40758310	s-he4	pmol/L (pmol/l)	38	42	0.00%
40758310	he4proteiini	pmol/l (pmol/l)	10	10	0.00%	Distribution not available
40758310	s-he4	PMOL/L (pmol/l)	7	8	0.00%	Distribution not available	Distribution not available
40758310	s-he4ihmisenepididymaalinenproteiini4	pmol/l (pmol/l)	7	7	0.00%	Distribution not available
40758310	p-he4	— (—)	6	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Solid cancers

2098

4692

2.69

322.83

1.5

1.4

209.79

60.47

pmol/l

22.03

2060

4582

Malignant neoplasm, wide definition

2156

4883

2.63

318.55

1.5

1.4

193.61

59.74

pmol/l

20.71

2115

4768

Malignant neoplasm, including Hilmo

2151

4882

2.63

316.90

1.5

1.4

193.92

59.70

pmol/l

20.74

2111

4767

Malignant neoplasm

2102

4772

2.64

313.50

1.5

1.4

197.73

60.10

pmol/l

20.78

2063

4659

Malignant neoplasm

2100

4772

2.64

312.66

1.5

1.4

197.82

60.14

pmol/l

20.76

2061

4659

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

428

224

31.98

307.65

1.8

1.5

847.16

84.69

pmol/l

21.63

416

214

GASTRO-related operations

1823

2817

3.32

307.65

1.5

1.3

146.64

59.93

pmol/l

8.90

1776

2740

Any gastric operation

1823

2817

3.32

307.65

1.5

1.3

146.64

59.93

pmol/l

8.90

1776

2740

Malignant neoplasm of corpus uteri, including Hilmo

790

779

12.48

307.65

1.4

187.23

78.56

pmol/l

5.41

780

755

malignant neoplasm of female genital organs, including Hilmo

2019

1734

14.45

307.65

1.6

1.4

378.10

74.76

pmol/l

36.47

1971

1692

Ovarian cyst

3063

1466

13.99

307.65

1.5

1.4

72.53

260.60

pmol/l

14.16

2989

1419

Malignant neoplasm of ovary, including Hilmo

1057

587

29.70

307.65

1.8

1.4

467.56

73.50

pmol/l

26.61

1019

569

Endometriosis

1591

1446

6.90

307.65

1.6

1.4

80.47

263.17

pmol/l

12.22

1544

1400

Malignant neoplasm of corpus uteri

719

689

12.87

307.65

1.4

190.43

80.54

pmol/l

4.73

712

670

Solid cancers, including Hilmo

2171

4805

2.70

307.65

1.5

1.4

193.97

60.00

pmol/l

20.97

2131

4693

Exclusions for E4_PCOS_CONSORTIUM

2830

5677

3.26

307.65

1.5

1.4

158.92

96.90

pmol/l

5.29

2767

5518

Ascites

432

416

11.78

307.65

1.7

1.4

736.42

142.31

pmol/l

13.50

413

408

Other symptoms and signs involving the digestive system and abdomen

1189

1648

8.19

307.65

1.6

1.4

161.07

115.10

pmol/l

2.42

1161

1614

Malignant neoplasm of ovary

806

439

30.70

307.65

1.8

1.4

507.50

78.15

pmol/l

21.85

775

423

Benign neoplasm of ovary

1013

2408

4.70

307.65

1.4

1.5

70.81

197.12

pmol/l

13.91

1006

2342

malignant neoplasm of female genital organs

1791

1505

15.27

307.65

1.6

1.4

394.25

76.30

pmol/l

34.50

1747

1469

Any event in cancer register

2334

5314

2.63

307.65

1.5

1.4

181.67

64.44

pmol/l

17.88

2286

5180

Neoplasms

1697

2363

3.86

307.65

1.6

1.3

122.03

51.02

pmol/l

6.22

1660

2265

Serous carcinoma of ovary, including Hilmo

534

290

30.95

307.65

2.0

1.4

642.84

83.91

pmol/l

17.78

511

279

Uterine polyps

985

1296

4.69

307.65

1.4

122.82

287.21

pmol/l

7.05

971

1258

Endometriosis of pelvic peritoneum

816

1078

7.54

307.65

1.5

1.4

81.23

237.44

pmol/l

8.60

796

1049

Endometriosis of ovary

1165

1185

10.58

307.65

1.6

1.4

55.37

272.76

pmol/l

15.39

1137

1149

Endometriosis ASRM stages 3,4

1308

3511

4.10

307.65

1.6

1.4

60.43

158.60

pmol/l

14.02

1278

3418

Unspecified/other endometriosis

524

567

10.06

307.65

1.5

1.4

67.44

193.80

pmol/l

4.46

503

552

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

559

987

5.98

303.38

1.7

1.4

533.20

77.44

pmol/l

13.29

546

959

Noninflammatory disorders of female genital tract

1146

1496

3.99

303.25

1.5

1.4

121.23

257.43

pmol/l

5.75

1116

1443

Polyp of the female genital tract

965

1319

4.34

295.89

1.4

131.68

283.96

pmol/l

6.02

946

1278

Congenital malformations of ovaries, fallopian tubes and broad ligaments

476

823

6.97

273.44

1.4

1.5

48.73

137.69

pmol/l

3.35

460

807

Female infertility

879

1289

4.27

270.98

1.5

1.4

102.29

229.57

pmol/l

5.76

856

1252

Female infertility, cervical, vaginal, other or unspecified origin

830

1271

4.37

269.68

1.5

1.4

97.48

228.49

pmol/l

5.97

810

1235

Congenital ovarian cysts

420

668

7.83

263.76

1.5

1.4

48.16

105.50

pmol/l

2.36

408

655

Postmenopausal bleeding

862

1133

4.19

244.33

1.4

155.26

315.89

pmol/l

5.17

845

1101

Congenital malformations of genital organs

543

1167

5.14

238.04

1.4

1.5

55.20

116.72

pmol/l

2.98

524

1141

Pain and other conditions associated with female genital organs and menstrual cycle

626

1225

4.46

230.24

1.5

1.4

63.55

228.47

pmol/l

11.76

598

1184

Excessive, frequent and irregular menstruation

952

1494

3.51

219.02

1.5

1.4

102.04

257.61

pmol/l

8.97

915

1441

Appendectomy

1706

7262

2.29

210.66

1.5

1.4

183.65

114.42

pmol/l

5.19

1667

7090

Adenomyosis (Endometriosis of uterus)

445

980

4.80

187.79

1.6

1.4

78.85

299.80

pmol/l

11.09

431

949

Endometriosis ASRM stages 1,2

837

2883

3.12

184.38

1.5

1.4

80.61

123.88

pmol/l

1.92

813

2812

Menorrhagia

827

1406

3.39

183.62

1.5

1.4

110.78

269.84

pmol/l

8.24

805

1364

Symptoms and signs involving the digestive system and abdomen

1766

4023

2.23

178.03

1.5

1.4

161.87

99.65

pmol/l

4.12

1714

3935

Hernia of abdominal wall, postoperative

399

828

4.94

177.90

1.5

1.3

203.81

70.05

pmol/l

4.40

392

806

Benign neoplasms

1865

4903

2.10

165.97

1.5

1.4

98.32

143.18

pmol/l

3.52

1822

4750

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

497

1259

3.95

164.82

1.5

1.4

275.89

76.78

pmol/l

6.46

487

1228

Other medical care

1117

3868

2.48

161.47

1.6

1.4

397.95

123.81

pmol/l

15.56

1082

3784

Endometriosis diagnosis and infertility diagnosis occurring together

561

1699

3.60

154.60

1.5

85.40

113.66

pmol/l

0.64

549

1663

Genitourinary diseases

583

783

3.77

147.18

1.4

143.67

210.82

pmol/l

1.17

568

755

Complications of procedures, not elsewhere classified

1781

7473

1.95

141.53

1.5

1.4

124.22

132.47

pmol/l

0.29

1731

7299

Abdominal and pelvic pain

1640

4023

2.07

138.52

1.5

1.4

154.54

99.65

pmol/l

2.27

1591

3935

Complications of surgical and medical care, not elsewhere classified

2090

7615

1.86

138.05

1.5

1.4

138.14

131.03

pmol/l

0.23

2034

7430

Deep endometriosis

454

1311

3.77

134.56

1.6

1.5

64.05

167.11

pmol/l

6.51

447

1273

Other noninflammatory disorders of uterus, except cervix

549

1100

3.46

133.35

1.5

1.4

182.09

310.82

pmol/l

2.59

539

1067

Other abnormal uterine and vaginal bleeding

527

1215

3.21

117.78

1.4

162.31

288.44

pmol/l

2.77

510

1173

Leiomyoma of uterus

1975

6216

1.83

117.10

1.4

117.73

149.54

pmol/l

1.42

1934

6069

Intestinal stricture

632

2454

2.64

108.20

1.6

1.4

245.01

185.05

pmol/l

1.60

616

2390

Complications of medical and surgical care

1544

7716

1.83

102.15

1.5

1.4

137.30

135.83

pmol/l

0.04

1508

7533

Salpingitis and oophoritis

655

2720

2.54

99.34

1.5

1.4

89.07

158.06

pmol/l

5.32

649

2656

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

282

745

3.90

93.17

1.7

1.4

235.11

70.64

pmol/l

6.75

276

722

Inflammatory diseases of female pelvic organs

1928

7962

1.69

92.07

1.5

1.4

100.04

136.89

pmol/l

2.45

1880

7755

Dysplasia of cervi uteri

477

1214

2.83

86.06

1.4

86.34

250.00

pmol/l

7.83

468

1179

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1236

6694

1.84

85.03

1.5

1.4

129.25

142.15

pmol/l

0.38

1210

6537

Paralytic ileus and intestinal obstruction

509

2073

2.51

78.79

1.6

1.4

229.52

180.69

pmol/l

1.10

495

2022

Oxycodone

745

3018

2.15

78.23

1.6

1.4

352.51

149.88

pmol/l

7.11

725

2947

Cervical polyps

256

729

3.66

76.34

1.3

1.4

132.44

283.43

pmol/l

3.33

251

709

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1144

6438

1.80

73.69

1.5

1.4

130.48

148.02

pmol/l

0.52

1119

6284

Malignant neoplasm of digestive organs, including Hilmo

575

1838

2.33

71.78

1.4

158.83

74.63

pmol/l

4.92

566

1793

Other menopausal disorders

537

1259

2.43

67.59

1.4

121.58

289.04

pmol/l

5.17

527

1226

Liquid cancers, including Hilmo

492

1850

2.38

66.90

1.6

1.4

206.53

73.29

pmol/l

8.82

484

1804

Other or unspecified ileus, impaction or obstruction

347

1274

2.79

66.56

1.5

1.4

273.41

205.85

pmol/l

1.00

337

1238

Malignant neoplasm, without specification of site, including Hilmo

109

174

6.54

65.65

1.6

1.4

686.55

88.66

pmol/l

2.31

109

168

Hydronephrosis

260

836

3.22

63.75

1.6

1.5

334.82

172.32

pmol/l

2.57

255

817

Abnormal findings on diagnostic imaging of other body structures

374

1492

2.60

61.36

1.4

137.42

173.64

pmol/l

0.90

363

1458

Congenital malformations, deformations and chromosomal abnormalities

1169

6678

1.68

58.88

1.4

82.71

118.22

pmol/l

3.75

1133

6513

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1273

7165

1.64

57.73

1.4

82.10

123.17

pmol/l

5.20

1231

6993

Female genital prolapse

512

1262

2.30

57.31

1.5

1.4

167.28

294.54

pmol/l

1.95

502

1225

Malignant neoplasm of digestive organs

483

1650

2.27

57.26

1.4

139.08

76.39

pmol/l

2.73

476

1611

Nausea and vomiting

467

2056

2.25

56.95

1.5

1.4

244.30

112.63

pmol/l

2.45

455

2005

Benign leiomyoma with endometriosis

483

2249

2.24

56.05

1.5

77.95

209.00

pmol/l

10.20

468

2192

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1856

6608

1.50

53.09

1.4

155.70

125.55

pmol/l

1.17

1811

6441

Anaemias

476

1390

2.24

51.98

1.6

1.4

141.83

47.52

pmol/l

3.22

464

1351

Persons encountering health services for specific procedures and health care

1866

7512

1.48

50.02

1.5

1.4

208.83

93.63

pmol/l

11.54

1812

7333

Any death

927

3827

1.71

47.96

1.6

1.4

498.82

115.81

pmol/l

15.67

896

3750

Malignant neoplasm of breast, including Hilmo

980

3764

1.70

47.51

1.4

141.95

63.46

pmol/l

7.54

955

3683

Malignant neoplasm of breast, HER2-negative, including Hilmo

979

3764

1.70

47.31

1.4

142.07

63.46

pmol/l

7.55

954

3683

Follow-up examination after treatment for conditions other than malignant neoplasms

871

3379

1.74

46.94

1.5

1.4

89.37

144.75

pmol/l

5.01

852

3310

Procreative management

677

3072

1.84

46.09

1.5

1.4

120.36

121.17

pmol/l

0.02

664

2998

Malignant neoplasm of breast, HER2-negative

952

3693

1.69

45.72

1.4

141.75

63.36

pmol/l

7.29

929

3613

Malignant neoplasm of breast

953

3702

1.69

45.50

1.4

141.60

63.31

pmol/l

7.29

930

3622

Postmenopausal atrophic vaginitis

455

1162

2.17

44.62

1.4

118.31

310.94

pmol/l

8.35

448

1131

Other diseases of intestines

1802

6954

1.45

44.17

1.5

1.4

139.11

115.99

pmol/l

1.03

1752

6779

Persons encountering health services in other circumstances, wide

1847

6616

1.44

43.13

1.5

1.4

152.47

125.62

pmol/l

1.00

1801

6449

Medical treatment for female infertility

656

3696

1.81

42.18

1.5

1.4

52.89

76.34

pmol/l

3.15

641

3606

Other female pelvic inflammatory diseases

469

2404

2.02

42.02

1.5

1.4

85.91

165.64

pmol/l

4.85

454

2336

Other noninflammatory disorders of vulva and perineum

191

656

2.99

41.86

1.4

93.31

303.97

pmol/l

6.11

186

631

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

564

1471

1.94

40.79

1.5

1.4

177.85

80.53

pmol/l

1.99

549

1441

Malignant neoplasm of breast, ER-positive, including Hilmo

717

3107

1.75

39.89

1.4

119.80

65.47

pmol/l

5.26

700

3039

Malignant neoplasm of breast, HER-positive

713

3103

1.74

39.26

1.4

120.14

65.51

pmol/l

5.26

696

3035

Ventral hernia

438

2236

2.00

39.13

1.5

184.34

178.85

pmol/l

0.07

430

2172

Opioids

1679

6067

1.44

38.54

1.5

1.4

152.64

103.34

pmol/l

2.69

1628

5922

Pain in joint

875

3298

1.64

38.13

1.4

115.92

141.03

pmol/l

0.66

852

3222

Persons encountering health services in other circumstances

728

4407

1.65

35.11

1.6

1.4

150.12

130.82

pmol/l

0.36

706

4295

Pleural effusion

209

827

2.57

34.78

1.5

421.16

196.85

pmol/l

3.17

199

804

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1029

5920

1.53

34.66

1.4

158.60

157.02

pmol/l

0.03

1000

5775

Carcinoma in situ of other and unspecified genital organs

102

278

4.08

33.64

1.3

1.5

120.86

272.03

pmol/l

1.23

102

273

Hernia of abdominal wall

647

3901

1.68

33.10

1.5

1.4

170.79

157.55

pmol/l

0.25

634

3795

Irregular menses

1311

6917

1.44

32.25

1.4

85.45

117.28

pmol/l

2.11

1280

6738

Fever of other and unknown origin

929

5322

1.52

31.32

1.5

1.4

172.31

131.60

pmol/l

1.18

910

5182

Pulmonary heart disease

438

2413

1.84

30.96

1.6

1.5

351.64

189.12

pmol/l

1.85

432

2343

Intestinal adhesions without obstruction

172

659

2.68

30.86

1.9

1.4

175.98

191.88

pmol/l

0.18

167

643

Pulmonary embolism

438

2418

1.84

30.76

1.6

1.5

351.64

191.14

pmol/l

1.81

432

2348

Parasetamol

1051

3560

1.50

30.07

1.5

1.4

138.58

102.97

pmol/l

1.00

1021

3466

Disorders of the thyroid gland

1580

7473

1.38

30.02

1.5

1.4

117.46

126.03

pmol/l

0.26

1538

7281

DVT of lower extremities and pulmonary embolism

604

3683

1.65

29.13

1.5

1.4

309.91

172.80

pmol/l

2.26

591

3591

Polycystic ovarian syndrome, consortium definition

1849

7958

1.35

29.02

1.4

117.66

132.90

pmol/l

0.64

1805

7746

Pain (limb, back, neck, head abdominally)

987

3295

1.51

28.99

1.5

1.4

145.90

141.02

pmol/l

0.08

956

3217

Cystitis

1499

6502

1.38

28.13

1.4

111.95

127.98

pmol/l

0.76

1465

6335

Pulmonary heart disease, diseases of pulmonary circulation

454

2613

1.76

27.71

1.6

1.5

377.24

187.04

pmol/l

2.29

448

2538

Colectomy operation

257

1231

2.13

27.56

1.5

176.49

190.73

pmol/l

0.16

251

1198

Misadventures to patients during surgical and medical care

269

1320

2.08

27.14

1.5

113.87

166.89

pmol/l

1.75

261

1287

Other disorders of urethra and urinary system

1283

6421

1.40

26.96

1.4

140.10

129.05

pmol/l

0.23

1248

6258

Hypothyreosis and Thyroxine purchase for inclusion criteria

1599

7880

1.34

24.98

1.5

1.4

132.82

129.04

pmol/l

0.10

1560

7681

Other functional intestinal disorders

746

4518

1.51

24.58

1.5

1.4

200.51

141.72

pmol/l

1.29

724

4408

Other nutritional deficiencies

1201

8002

1.38

24.22

1.4

132.37

121.96

pmol/l

0.29

1161

7811

General symptoms and signs

1707

6478

1.33

24.17

1.5

1.4

132.04

121.80

pmol/l

0.41

1665

6314

Hypothyroidism, other/unspecified

1510

7444

1.34

24.17

1.5

1.4

122.30

126.34

pmol/l

0.12

1471

7254

Venous thromboembolism

774

5037

1.49

24.04

1.5

1.4

268.68

156.40

pmol/l

2.43

757

4908

Other diseases of urinary system

1541

6503

1.34

23.55

1.4

128.61

127.97

pmol/l

0.01

1500

6336

Medicines for HER+ breast cancer

872

5663

1.46

23.33

1.6

1.4

159.07

164.52

pmol/l

0.11

850

5530

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1620

7786

1.32

23.30

1.5

1.4

139.60

123.97

pmol/l

0.61

1569

7597

Headache

1150

6477

1.38

22.75

1.4

89.24

121.78

pmol/l

3.22

1116

6313

Follow-up examination after treatment for malignant neoplasms

191

887

2.20

22.37

2.1

1.4

218.03

226.68

pmol/l

0.05

186

867

Obesity due to excess calories

873

6148

1.43

22.13

1.4

137.64

116.71

pmol/l

0.52

842

6004

Agranulocytosis

217

1069

2.08

21.85

1.7

1.5

260.03

181.30

pmol/l

0.85

212

1048

First line medication for Crohn's disease

1709

7091

1.30

21.60

1.5

1.4

193.74

101.90

pmol/l

5.96

1664

6907

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1542

7986

1.31

20.89

1.5

1.4

163.64

126.01

pmol/l

1.90

1504

7786

Fentanyl

155

678

2.32

20.84

1.7

1.5

274.22

169.45

pmol/l

1.16

150

657

Dysphagia

306

1710

1.81

20.82

1.4

118.89

120.21

pmol/l

0.02

295

1675

Tramadol

1229

5498

1.35

20.50

1.5

1.4

177.37

109.63

pmol/l

2.69

1193

5380

Malignant neoplasm of breast, ER-negative, including Hilmo

393

2220

1.68

20.23

1.5

1.4

207.73

71.22

pmol/l

4.55

383

2167

Obesity and other hyperalimentation

1124

7886

1.35

19.78

1.4

134.86

122.19

pmol/l

0.34

1089

7699

Hypothyroidism, levothyroxine purchases

420

1417

1.68

19.74

1.6

1.4

75.67

47.31

pmol/l

2.86

404

1374

Hypothyroidism and >3 levothyroxin purchases

420

1417

1.68

19.74

1.6

1.4

75.67

47.31

pmol/l

2.86

404

1374

Obesity

1120

7872

1.35

19.67

1.4

135.20

122.15

pmol/l

0.35

1085

7685

All kidney diseases

1575

8205

1.29

19.51

1.5

1.4

212.11

111.04

pmol/l

6.14

1530

8001

Hypothyroidism (congenital or acquired)

419

1417

1.67

19.44

1.5

1.4

75.59

47.31

pmol/l

2.85

404

1374

Codeine

1458

6039

1.31

19.43

1.4

113.74

103.60

pmol/l

0.32

1409

5897

Other pleural conditions

123

506

2.47

19.11

1.4

1.5

417.94

208.07

pmol/l

2.03

118

492

Diseases of peritoneum

175

840

2.13

18.93

1.6

1.5

172.05

195.85

pmol/l

0.21

170

822

Depression medications

455

1418

1.63

18.62

1.4

155.90

47.30

pmol/l

1.88

439

1375

Hypothyroidism, strict autoimmune

1285

6433

1.32

18.44

1.5

1.4

128.18

119.72

pmol/l

0.24

1251

6273

Low back pain

1252

6428

1.32

18.40

1.4

110.00

129.92

pmol/l

0.93

1210

6265

Other diseases of blood and blood-forming organs, wide

339

2037

1.69

17.99

1.6

1.4

212.46

173.23

pmol/l

0.56

332

1984

Paracetamol or NSAID medication

185

441

2.13

17.64

1.4

144.37

115.27

pmol/l

0.19

180

427

Malignant neoplasm of breast, HER-negative

351

2061

1.66

17.37

1.5

1.4

191.89

72.29

pmol/l

3.82

343

2014

Any reimbursement code in KELA

981

3610

1.37

17.37

1.5

1.4

147.16

55.37

pmol/l

4.40

964

3511

Malignant neoplasm of skin

534

2406

1.51

17.04

1.5

1.4

179.70

70.38

pmol/l

3.39

521

2346

L02BA Anti-estrogens

405

2587

1.60

17.03

1.4

1.5

117.87

166.96

pmol/l

1.56

398

2524

Renal tubulo-interstitial diseases

1352

7725

1.29

16.73

1.5

1.4

233.57

114.25

pmol/l

6.46

1311

7535

Hypothyroidism, strict autoimmune, 3 medication purchases required

1484

7858

1.28

16.70

1.4

142.76

129.30

pmol/l

0.39

1444

7662

Medical observation and evaluation for suspected diseases and conditions

908

3389

1.38

16.66

1.6

1.4

141.66

144.52

pmol/l

0.05

883

3320

Disorders of gallbladder, biliary tract and pancreas

1506

7441

1.27

15.71

1.4

140.33

134.62

pmol/l

0.13

1474

7264

Cardiovascular diseases (excluding rheumatic etc)

1136

4972

1.31

15.71

1.5

1.4

128.67

82.61

pmol/l

1.98

1110

4839

Malignant neoplasm of skin, including Hilmo

564

2594

1.46

15.46

1.5

1.4

151.95

68.91

pmol/l

3.48

551

2530

Sequelae with surgical and medical care as external cause

303

1849

1.66

15.24

1.5

1.4

134.71

177.37

pmol/l

0.98

297

1801

Cholecystectomy

1162

7674

1.29

15.13

1.4

139.85

140.87

pmol/l

0.02

1136

7493

Pain in limb

1288

6412

1.28

15.10

1.4

140.82

124.92

pmol/l

0.32

1248

6255

Malignant melanoma, including Hilmo

174

909

1.93

14.84

1.4

89.05

71.33

pmol/l

1.03

169

882

Fenamates

238

916

1.79

14.80

1.4

172.96

135.21

pmol/l

0.34

230

885

Examination and observation for other reasons

817

3388

1.37

14.77

1.5

1.4

137.59

144.48

pmol/l

0.09

795

3319

Gastrointestinal diseases

940

3533

1.34

14.60

1.5

1.4

145.34

108.02

pmol/l

0.91

915

3442

Lower back pain or/and sciatica

1651

8304

1.24

14.58

1.5

1.4

113.09

133.38

pmol/l

0.82

1597

8102

Constipation

1326

7125

1.27

14.22

1.4

178.67

135.35

pmol/l

1.33

1291

6965

Heartburn

158

814

1.97

14.12

1.5

1.4

95.53

120.18

pmol/l

0.50

153

796

Abnormalities of breathing

1396

6368

1.26

13.91

1.4

156.26

119.05

pmol/l

1.08

1362

6214

All chronic kidney diseases

671

3901

1.38

13.57

1.6

1.4

326.62

141.63

pmol/l

5.09

648

3808

Other diseases of pleura

443

2620

1.48

13.35

1.5

338.05

197.16

pmol/l

3.64

428

2552

Other malignant neoplasms of skin (=non-melanoma skin cancer)

453

2093

1.48

13.11

1.5

1.4

195.30

72.99

pmol/l

3.11

440

2039

Cholelithiasis

1330

7278

1.25

13.08

1.4

143.16

136.61

pmol/l

0.13

1308

7106

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

475

2203

1.46

13.08

1.5

1.4

192.43

71.78

pmol/l

3.31

464

2148

Other soft tissue disorders, not elsewhere classified

1404

6425

1.25

12.97

1.4

149.74

124.79

pmol/l

0.54

1363

6268

Basal cell carcinoma, including Hilmo

458

2122

1.47

12.92

1.5

1.4

192.35

72.70

pmol/l

3.04

444

2068

Sequelae of external causes of morbidity and mortality

363

2404

1.52

12.90

1.5

1.4

126.40

176.30

pmol/l

1.44

353

2339

Unspecific neurodegenerative disorder

187

2220

0.57

12.69

1.4

1.5

210.97

257.47

pmol/l

0.40

180

2158

Cardiovascular diseases

1041

4296

1.29

12.69

1.5

1.4

116.13

79.65

pmol/l

1.33

1009

4181

Malignant neoplasm of other connective and soft tissue, including Hilmo

182

3.03

12.55

1.3

1.4

148.26

81.75

pmol/l

0.60

176

Major coronary heart disease event excluding revascularizations

356

3508

0.67

12.55

1.5

1.4

224.74

182.83

pmol/l

0.41

351

3417

Cholelithiasis, broad definition with cholecystitis

1361

7314

1.24

12.53

1.4

144.04

136.16

pmol/l

0.17

1339

7142

Diverticular disease of intestine

932

4477

1.30

12.38

1.5

1.4

152.89

150.42

pmol/l

0.04

909

4382

Oedema, not elsewhere classified

477

3279

1.43

12.34

1.6

1.4

175.46

158.50

pmol/l

0.30

465

3196

Basal cell carcinoma

436

2035

1.47

12.32

1.5

1.4

200.21

73.55

pmol/l

3.07

422

1984

Inflammatory disease of uterus

333

2195

1.54

12.31

1.5

1.4

127.31

124.09

pmol/l

0.03

326

2143

Pain, not elsewhere classified

461

3232

1.44

12.27

1.5

1.4

96.76

138.61

pmol/l

2.16

454

3152

Other disorders of the genitourinary system

254

1575

1.64

12.24

1.6

1.5

92.33

210.83

pmol/l

5.86

247

1537

Benzodiazepine use

1512

8362

1.22

12.12

1.4

170.53

123.64

pmol/l

1.68

1476

8151

Dermatitis and eczema

1657

8111

1.21

11.88

1.4

104.85

137.28

pmol/l

2.62

1613

7906

Urinary track infection

1447

5911

1.24

11.77

1.4

127.32

122.20

pmol/l

0.16

1413

5763

Bacterial infection, other or unspecified

669

4217

1.35

11.75

1.6

1.4

300.02

145.50

pmol/l

3.41

652

4115

Other disorders of skin and subcutaneous tissue

1067

7158

1.26

11.74

1.5

1.4

105.07

151.93

pmol/l

5.51

1037

6995

Bacterial infection, other or unspecified, including avohilmo

751

4676

1.32

11.68

1.5

1.4

284.32

139.04

pmol/l

3.64

730

4562

Sleep disorders

1433

8090

1.22

11.53

1.4

87.24

140.98

pmol/l

6.44

1390

7891

Neurological diseases, wide definition

442

1529

1.46

11.48

1.4

122.97

123.85

pmol/l

0.01

425

1491

Insomnia

1437

8214

1.22

11.34

1.4

85.46

139.66

pmol/l

6.71

1391

8013

Other diseases of intestine

196

1158

1.71

11.29

1.4

194.50

185.22

pmol/l

0.07

188

1132

Malignant neoplasm of rectum, including Hilmo

451

2.15

11.09

1.5

1.4

194.58

79.87

pmol/l

0.88

434

Dyspnoea

1325

7832

1.23

10.86

1.5

1.4

197.55

124.73

pmol/l

2.61

1291

7636

Gastro-oesophageal reflux disease

999

6723

1.26

10.69

1.4

145.57

138.36

pmol/l

0.14

974

6571

Degenerative diseases of the nervous system

146

1852

0.56

10.69

1.3

1.5

249.38

270.43

pmol/l

0.12

140

1798

In situ neoplasms

636

4836

1.32

10.30

1.4

1.5

118.13

159.29

pmol/l

1.95

621

4710

Certain infectious and parasitic diseases

1492

6197

1.21

10.21

1.4

138.64

115.58

pmol/l

0.98

1439

6056

Dementia

227

2424

0.64

10.10

1.4

1.5

271.44

237.13

pmol/l

0.17

217

2356

Conjunctivitis (acute, non atopic), including avohilmo

1467

7369

1.21

10.00

1.4

99.44

141.72

pmol/l

3.87

1436

7170

Dementia, including avohilmo

251

2611

0.65

9.99

1.4

1.5

250.73

235.06

pmol/l

0.08

240

2539

Migraine

1011

6339

1.25

9.93

1.4

69.08

127.26

pmol/l

12.59

979

6187

Disorders of thyroid, IBD co-morbidities

308

1412

1.51

9.92

1.3

1.4

100.97

130.38

pmol/l

0.63

299

1384

Use of anticholinesterases

147

1950

0.58

9.90

1.4

1.5

172.25

275.46

pmol/l

1.19

141

1893

N06DA Anticholinesterases

147

1950

0.58

9.90

1.4

1.5

172.25

275.46

pmol/l

1.19

141

1893

Codeine or tramadol medication

1682

7692

1.19

9.88

1.4

119.87

129.92

pmol/l

0.33

1628

7510

Any dementia

184

2059

0.61

9.62

1.4

1.5

317.79

254.08

pmol/l

0.27

177

2002

Alzheimer disease

129

1631

0.56

9.60

1.4

1.5

268.06

285.72

pmol/l

0.09

124

1580

Behavioural syndromes associated with physiological disturbances and physical factors

1433

8096

1.20

9.59

1.4

87.10

141.06

pmol/l

6.54

1391

7897

Enlarged lymph nodes

221

1406

1.59

9.57

1.4

142.17

153.33

pmol/l

0.13

216

1368

L02BG Aromatase inhibitors

629

4777

1.31

9.50

1.6

1.4

162.19

180.64

pmol/l

0.50

612

4664

Symptoms and signs involving the circulatory and respiratory systems

1519

6368

1.20

9.49

1.5

1.4

112.78

119.05

pmol/l

0.25

1479

6214

Diseases of oesophagus, stomach and duodenum

1557

7732

1.19

9.41

1.4

148.65

127.69

pmol/l

0.57

1522

7545

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

418

3032

1.40

9.40

1.4

81.45

119.54

pmol/l

2.23

401

2951

Coxibs

289

1001

1.52

9.40

1.6

1.4

138.50

128.69

pmol/l

0.09

280

965

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

376

2.15

9.31

1.4

199.32

83.42

pmol/l

0.70

360

Triptan medication for migraine, single purchase ok

1322

7458

1.21

9.18

1.4

78.75

129.09

pmol/l

9.18

1289

7268

Migraine, single triptan purchase ok & required. ICD-code if available is included

1322

7458

1.21

9.18

1.4

78.75

129.09

pmol/l

9.18

1289

7268

Anxiety disorders

1416

8147

1.20

9.09

1.5

1.4

119.61

131.40

pmol/l

0.41

1384

7938

Neurotic, stress-related and somatoform disorders

1407

8126

1.20

9.07

1.5

1.4

119.88

130.74

pmol/l

0.36

1375

7917

Polycystic ovarian syndrome, broad definition

270

1825

1.50

9.01

1.4

52.72

78.52

pmol/l

2.02

264

1771

Other noninfective gastroenteritis and colitis

344

2425

1.43

9.01

1.4

109.52

166.18

pmol/l

2.11

335

2356

Iron deficiency anaemia

610

4610

1.31

8.97

1.5

1.4

133.77

162.60

pmol/l

0.96

593

4489

Organic, including symptomatic, mental disorders

305

3082

0.69

8.97

1.5

258.25

215.14

pmol/l

0.29

294

3002

Other septicaemia, including avohilmo

419

2868

1.38

8.89

1.6

1.4

220.60

164.36

pmol/l

1.61

411

2799

Angina pectoris

378

3464

0.72

8.78

1.5

1.4

148.85

186.89

pmol/l

1.22

370

3379

Other specific joint derangements/joint disorders

1124

5765

1.22

8.72

1.4

110.00

115.83

pmol/l

0.15

1094

5614

Other and unspecified iron deficiency

493

3701

1.34

8.68

1.5

1.4

132.79

168.25

pmol/l

1.00

481

3596

Acute tubulo-interstitial nephritis

928

6355

1.24

8.66

1.5

1.4

205.28

122.04

pmol/l

2.55

899

6197

Hypertension, essential

1158

5399

1.22

8.66

1.5

1.4

145.09

115.88

pmol/l

1.01

1132

5280

Other septicaemia

408

2809

1.38

8.62

1.6

1.4

219.24

165.20

pmol/l

1.51

400

2740

General examination and investigation of persons without complaint and reported diagnosis

821

3388

1.26

8.53

1.5

1.4

150.51

144.48

pmol/l

0.09

800

3319

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1356

7197

1.19

8.50

1.4

164.52

126.29

pmol/l

1.04

1330

7029

Septicaemia

461

3137

1.35

8.42

1.6

1.4

217.41

159.59

pmol/l

1.67

452

3060

Anxiety disorders, excluding more controls

1294

6925

1.20

8.39

1.5

1.4

125.25

133.61

pmol/l

0.24

1264

6757

Use of memantine

102

1485

0.55

8.38

1.5

1.4

218.87

298.48

pmol/l

0.61

1434

Use of other anti-dementia drugs

102

1485

0.55

8.38

1.5

1.4

218.87

298.48

pmol/l

0.61

1434

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1477

8026

1.18

8.37

1.4

124.17

132.38

pmol/l

0.22

1422

7836

Hypertensive diseases (excluding secondary)

848

3958

1.25

8.35

1.5

1.4

149.40

92.52

pmol/l

1.99

832

3870

Oxicams

238

887

1.53

8.18

1.4

197.09

139.33

pmol/l

0.55

230

856

Endocrine, nutritional and metabolic diseases

1153

4818

1.21

8.17

1.5

1.4

134.71

104.20

pmol/l

0.99

1121

4695

Follow-up care involving plastic surgery

442

2.00

8.08

1.7

1.4

69.48

162.85

pmol/l

1.54

433

Other special examinations and investigations of persons without complaint or reported diagnosis

835

3390

1.25

8.06

1.4

104.15

144.54

pmol/l

2.25

810

3321

Malignant neoplasm of rectum

372

2.06

8.02

1.3

1.4

153.91

83.51

pmol/l

0.45

357

Explicit Sepsis, including avohilmo

537

3744

1.31

7.96

1.5

1.4

198.21

166.93

pmol/l

0.74

526

3647

Nutritional anaemias

678

5128

1.27

7.92

1.5

1.4

147.55

159.36

pmol/l

0.24

661

4994

Any dementia, excluding more controls

182

1932

0.64

7.87

1.4

1.5

319.25

243.07

pmol/l

0.33

175

1881

Explicit Sepsis

522

3656

1.31

7.77

1.6

1.4

197.65

169.03

pmol/l

0.65

511

3562

Coronary atherosclerosis

475

3925

0.76

7.71

1.4

202.40

177.85

pmol/l

0.32

463

3831

Phlebitis and thrombophlebitis (not including DVT)

311

2225

1.41

7.62

1.5

1.4

220.98

160.84

pmol/l

0.68

300

2160

Malaise and fatigue

706

4443

1.26

7.55

1.5

1.4

201.65

141.94

pmol/l

1.27

682

4329

Other bacterial diseases, including avohilmo

1449

7729

1.17

7.44

1.5

1.4

210.52

116.75

pmol/l

4.48

1407

7541

Non-invasive ventilation

390

2502

1.35

7.39

1.5

1.4

94.84

112.11

pmol/l

0.60

362

2442

Other bacterial diseases

1264

7085

1.18

7.37

1.5

1.4

238.89

123.00

pmol/l

4.96

1230

6922

Abnormalities of heart beat

548

4154

1.29

7.32

1.6

1.4

103.77

137.65

pmol/l

1.79

539

4058

Acute upper respiratory infections

1547

7972

1.17

7.31

1.5

1.4

111.20

137.93

pmol/l

1.84

1505

7778

Hepatomegaly and splenomegaly, not elsewhere classified

4.45

7.29

1.6

1.3

91.78

150.81

pmol/l

0.29

Dorsalgia

1423

6443

1.17

7.15

1.5

1.4

105.94

129.76

pmol/l

0.91

1382

6279

Benign neoplasm of colon, rectum, anus and anal canal

766

5270

1.23

7.05

1.4

138.67

175.65

pmol/l

1.66

750

5137

Contraceptive management

628

3492

1.26

6.97

1.5

1.4

101.96

115.61

pmol/l

0.29

613

3416

Ischaemic heart disease, wide definition

651

4982

0.80

6.89

1.4

227.66

167.29

pmol/l

0.90

635

4864

Noninfective enteritis and colitis

622

4972

1.26

6.86

1.4

96.48

141.18

pmol/l

3.26

605

4844

Disorders of eyelid, lacrimal system and orbit

1270

7941

1.18

6.86

1.4

93.64

143.32

pmol/l

7.40

1239

7747

Chronic diseases of tonsils and adenoids

1218

6523

1.18

6.85

1.4

92.00

133.23

pmol/l

3.60

1184

6370

Atrophic disorders of skin

301

2189

1.39

6.81

1.5

1.4

87.34

180.99

pmol/l

7.04

293

2133

Adenocarcinoma and papilloma adenocarcinoma of rectum

363

1.97

6.71

1.3

1.4

214.14

84.13

pmol/l

0.69

348

Other reaction to severe stress, and adjustment disorders

631

5074

1.25

6.68

1.5

1.4

130.31

108.46

pmol/l

0.51

617

4935

Sleep disorders (combined)

1582

7163

1.16

6.62

1.4

108.91

143.76

pmol/l

2.61

1535

6990

Other degenerative diseases of the nervous system

212

2228

0.69

6.55

1.3

1.5

157.95

167.51

pmol/l

0.08

206

2178

Acetic acid derivatives and related substances

274

999

1.42

6.54

1.5

1.4

188.93

128.89

pmol/l

0.65

267

963

Other heart diseases

720

3804

1.24

6.53

1.5

1.4

154.94

93.90

pmol/l

1.93

699

3715

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

746

3836

1.23

6.51

1.4

143.05

94.16

pmol/l

1.55

732

3749

Female infertility, uterine origin

6.42

6.48

1.9

1.3

63.81

82.85

pmol/l

0.30

Bacterial pneumoniae

267

3235

0.72

6.47

1.5

1.4

130.62

170.97

pmol/l

1.22

258

3153

Hypothyroidism, drug reimbursement

224

1082

1.46

6.35

1.5

1.4

63.26

49.73

pmol/l

1.87

219

1060

DVT of lower extremities

218

1517

1.45

6.32

1.5

262.05

189.32

pmol/l

0.56

211

1473

Bacterial pneumonia (organism specified)

282

3467

0.73

6.19

1.5

1.4

138.69

174.61

pmol/l

0.91

273

3373

Peripheral artery disease

192

2198

0.69

6.16

1.5

238.97

238.82

pmol/l

0.00

186

2132

Acute renal failure

189

1286

1.48

6.15

1.8

1.4

345.16

213.28

pmol/l

1.85

179

1252

Cardiac arrhythmias

992

5365

1.19

6.12

1.4

117.77

98.21

pmol/l

0.64

955

5249

Benign neoplasm: Colon

620

4717

1.24

6.08

1.4

136.77

184.02

pmol/l

2.22

605

4597

Diseases of liver

406

3138

1.30

6.05

1.4

185.30

161.28

pmol/l

0.40

396

3060

Inguinal hernia

251

2308

0.72

6.04

1.5

1.4

147.04

170.83

pmol/l

0.30

245

2237

Asthma, unspecified (mode)

810

4857

1.21

6.02

1.5

1.4

188.68

120.94

pmol/l

1.59

797

4753

Other antidepressants

1360

5995

1.16

6.02

1.5

1.4

131.48

133.91

pmol/l

0.05

1318

5850

Intestinal infectious diseases, including avohilmo, including avohilmo

1627

7938

1.14

5.96

1.4

132.69

132.92

pmol/l

0.01

1571

7751

Asthma, unspecified (mode), excluding more controls

791

4703

1.21

5.89

1.5

1.4

176.91

113.74

pmol/l

1.59

778

4604

All anxiety disorders

1004

6621

1.18

5.86

1.4

82.26

111.71

pmol/l

2.81

988

6456

Atrial fibrillation and flutter

387

1911

1.31

5.84

1.4

213.04

130.25

pmol/l

1.07

372

1868

Other dorsopathies, not elsewhere classified

1427

6444

1.15

5.80

1.5

1.4

103.58

129.74

pmol/l

1.65

1386

6280

Atherosclerosis, excluding cerebral and coronary sclerosis

172

1974

0.68

5.79

1.5

247.35

249.56

pmol/l

0.02

164

1912

Benign neoplasm of other and unspecified endocrine glands

183

1258

1.47

5.74

1.6

1.5

110.30

173.26

pmol/l

2.03

177

1231

Recurrent or chronic depression

623

3517

1.23

5.73

1.5

1.4

95.65

135.45

pmol/l

2.05

608

3443

Other chronic obstructive pulmonary disease, including avohilmo

325

3509

0.76

5.70

1.5

1.4

243.34

185.27

pmol/l

0.53

319

3423

Diseases of arteries, arterioles and capillaries

474

4363

0.79

5.67

1.4

178.76

181.37

pmol/l

0.04

459

4255

Other diseases of anus and rectum

370

2842

1.30

5.64

1.4

167.02

162.30

pmol/l

0.04

356

2765

Other disorders of fluid, electrolyte and acid-base balance

365

2643

1.31

5.64

1.6

1.4

299.63

178.92

pmol/l

1.57

350

2584

Other heart diseases, wide

1377

7258

1.15

5.61

1.4

134.57

118.71

pmol/l

0.55

1327

7092

Haematosalpinx/Haematoma of broad ligament

9.04

5.58

3.2

1.4

53.18

95.50

pmol/l

0.46

Abnormal results of function studies

123

783

1.59

5.56

1.4

1.5

198.94

166.90

pmol/l

0.14

117

764

Irritable bowel syndrome

458

3639

1.27

5.54

1.4

92.91

130.12

pmol/l

1.59

440

3553

Persons encountering health services for examination and investigation

811

3390

1.20

5.54

1.5

1.4

146.25

144.54

pmol/l

0.02

795

3321

Depression or dysthymia

857

3928

1.19

5.51

1.4

131.60

148.40

pmol/l

0.39

835

3841

Hypertension

1142

5542

1.17

5.46

1.5

1.4

154.08

114.05

pmol/l

1.57

1119

5422

Hypertensive diseases

1142

5543

1.17

5.46

1.5

1.4

154.08

114.04

pmol/l

1.57

1119

5423

Bacterial pneumonia, not elsewhere classified

256

3032

0.74

5.43

1.5

1.4

133.73

172.20

pmol/l

1.06

247

2951

Mood [affective] disorders

1474

8286

1.14

5.43

1.4

106.56

135.58

pmol/l

2.19

1434

8078

Unspecified urinary incontinence

153

1030

1.51

5.40

1.4

1.5

79.20

194.13

pmol/l

6.69

144

1002

Persons encountering health services in circumstances related to reproduction

745

4162

1.20

5.37

1.5

1.4

139.74

129.85

pmol/l

0.18

730

4061

Propionic acid derivatives

272

1002

1.37

5.29

1.4

194.19

128.61

pmol/l

0.52

264

966

Mood disorders

1474

8288

1.14

5.28

1.4

106.46

136.02

pmol/l

2.25

1434

8080

Depression

1402

8224

1.14

5.25

1.4

104.82

134.20

pmol/l

2.16

1368

8018

Benign lipomatous neoplasm

375

2935

1.29

5.16

1.4

1.5

168.09

167.44

pmol/l

0.01

367

2856

Selective serotonin reuptake inhibitors

1321

5995

1.15

5.13

1.5

1.4

122.75

133.91

pmol/l

0.34

1287

5850

Acquired atrophy of ovary and fallopian tube

7.52

5.10

1.7

1.3

53.09

87.94

pmol/l

0.43

Endometriosis in cutaneous scar

6.46

5.04

1.8

1.3

41.17

87.10

pmol/l

0.82

Stroke, including SAH

465

4133

0.80

4.98

1.5

1.4

230.94

176.28

pmol/l

0.66

456

4028

Dorsopathies

1446

6445

1.14

4.97

1.5

1.4

107.29

129.73

pmol/l

1.27

1405

6281

Sulfonylureas

137

1606

0.67

4.94

1.4

1.5

392.73

225.21

pmol/l

0.65

132

1558

Infections of the skin and subcutaneous tissue

713

5898

1.19

4.94

1.5

1.4

187.48

125.85

pmol/l

0.90

696

5739

Anti-inflammatory and antirheumatic products, non-steroids

268

1002

1.35

4.79

1.5

1.4

234.24

128.61

pmol/l

0.88

261

966

214

1567

1.38

4.77

1.4

140.95

133.12

pmol/l

0.09

208

1530

COPD

250

2694

0.75

4.77

1.5

1.4

231.01

193.01

pmol/l

0.32

245

2628

Haemorrhoids and perianal venous thrombosis

415

3297

1.26

4.76

1.4

152.23

161.26

pmol/l

0.10

408

3210

Major coronary heart disease event

804

5640

0.85

4.71

1.4

209.94

155.96

pmol/l

1.09

790

5506

Other embolism and thrombosis

151

1043

1.46

4.69

1.5

286.91

182.07

pmol/l

0.38

142

1017

Myalgia

407

3260

1.26

4.68

1.5

1.4

167.92

133.30

pmol/l

0.30

399

3183

Other diseases of the digestive system

277

2116

1.31

4.61

1.7

1.4

156.37

218.46

pmol/l

1.42

269

2047

Other/unspecified dorsalgia

551

4504

1.21

4.60

1.5

1.4

114.36

147.85

pmol/l

1.19

539

4394

Atrial fibrillation and flutter with reimbursement

294

1418

1.31

4.53

1.4

227.96

148.94

pmol/l

0.72

286

1385

Stroke, excluding SAH

421

3760

0.81

4.53

1.5

1.4

243.20

183.75

pmol/l

0.65

413

3665

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1079

7325

1.15

4.48

1.4

88.71

118.99

pmol/l

2.28

1051

7151

Other anaemias

444

3370

1.24

4.48

1.6

1.4

197.92

197.19

pmol/l

0.01

430

3282

Injuries to the head

1290

8649

0.88

4.48

1.4

121.08

130.74

pmol/l

0.34

1245

8437

Diseases of the skin and subcutaneous tissue

1358

6022

1.13

4.43

1.5

1.4

118.48

132.33

pmol/l

0.57

1315

5863

Exposure to other specified factors

879

8716

0.86

4.43

1.4

101.58

129.59

pmol/l

1.98

845

8500

Mucinous and mucinous cystic tumor of rectum

7.83

4.41

1.6

1.4

82.38

64.33

pmol/l

—

Abnormal findings on diagnostic imaging of lung

495

3855

1.22

4.40

1.4

186.18

184.73

pmol/l

0.01

484

3762

Covid-19 confirmed case

422

3416

1.24

4.35

1.5

186.38

167.28

pmol/l

0.24

412

3314

Other and unspecified anaemias

437

3335

1.23

4.33

1.6

1.4

195.70

196.18

pmol/l

0.01

424

3247

Anxiety (asthma-related co-morbidities)

977

6465

1.15

4.30

1.5

1.4

83.40

126.77

pmol/l

4.57

962

6304

Adjustment and management of implanted device

135

929

1.46

4.29

1.5

1.4

259.62

158.69

pmol/l

0.86

128

904

Polyuria

199

1466

1.36

4.28

1.4

1.5

110.56

165.13

pmol/l

1.23

187

1426

Noninfectious colitis NAS

181

1315

1.39

4.28

1.5

97.65

168.35

pmol/l

2.59

174

1280

Other misadventures during surgical and medical care

186

2.09

4.25

1.3

1.5

94.82

275.91

pmol/l

1.16

181

Single spontaneous delivery

623

3903

0.84

4.24

1.4

198.74

158.69

pmol/l

0.53

602

3793

Other chronic obstructive pulmonary disease

239

2560

0.76

4.19

1.5

1.4

227.91

196.03

pmol/l

0.25

234

2497

Episodal and paroxysmal disorders

1546

7013

1.12

4.17

1.4

106.32

136.01

pmol/l

1.76

1495

6839

Squamous cell neoplasms and carcinomas of the skin

284

1.84

4.17

1.5

1.4

160.90

95.91

pmol/l

1.48

272

Factors influencing health status and contact with health services

253

958

1.33

4.16

1.4

250.07

129.46

pmol/l

1.02

248

940

Inflammatory disease of cervix uteri

119

809

1.49

4.13

1.4

1.5

208.86

197.01

pmol/l

0.04

114

789

Malignant neoplasm of vagina

6.16

4.12

1.1

120.90

274.80

pmol/l

—

Asthma (diagnoses ohter than nonallergic)

1222

8750

1.13

4.10

1.5

1.4

161.36

125.93

pmol/l

1.03

1198

8515

Oter anti-inflammatory and antirheumatic agents, non-steroids

193

772

1.38

4.08

1.5

1.4

130.55

152.29

pmol/l

0.35

187

746

Benign neoplasm of other and ill-defined parts of digestive system

224

1696

1.33

4.07

1.3

1.5

186.92

192.51

pmol/l

0.03

216

1658

Ischaemic Stroke, excluding all haemorrhages

382

3470

0.81

4.07

1.5

1.4

222.34

194.68

pmol/l

0.35

374

3383

Special screening examination for infectious and parasitic diseases

332

1919

1.27

4.05

1.4

80.32

99.61

pmol/l

0.44

314

1879

Functional dyspepsia

409

3336

1.23

4.04

1.5

1.4

102.29

147.25

pmol/l

2.33

399

3249

Acute pharyngitis

179

1298

1.37

4.03

1.5

58.13

110.24

pmol/l

2.54

166

1262

Other diseases of liver

233

1777

1.32

4.02

1.3

1.4

197.09

165.25

pmol/l

0.35

225

1735

Heart failure, not strict

851

4949

1.16

4.02

1.6

1.4

255.32

148.70

pmol/l

2.65

828

4833

Excluding asthma or asthma-COPD overlap

1141

5033

1.14

4.01

1.4

156.87

118.40

pmol/l

1.46

1106

4923

Autoimmune diseases related-to ILD

1166

8623

1.13

4.01

1.4

102.43

134.22

pmol/l

3.18

1137

8405

Renal failure

399

2759

1.23

3.99

1.7

1.5

338.19

211.84

pmol/l

2.32

378

2697

External causes of morbidity and mortality

980

4283

1.15

3.98

1.4

122.84

138.00

pmol/l

0.36

955

4186

Asthma (mode)

1089

5027

1.14

3.97

1.5

1.4

117.83

119.02

pmol/l

0.02

1063

4920

Malignant neoplasm of uterus, part unspecified

13.81

3.89

1.5

1.0

98.33

75.80

pmol/l

—

Diagnoses used for exclusion with ILD

243

1872

1.30

3.89

1.4

188.50

169.86

pmol/l

0.15

236

1830

Metabolic disorders

1289

6887

1.12

3.87

1.5

1.4

175.35

124.02

pmol/l

1.89

1254

6740

Car occupant injured in other and unspecified transport accidents

248

1920

1.30

3.85

1.5

91.18

127.32

pmol/l

0.99

237

1868

Emergency coronary revascularization (for ACS)

805

5601

0.87

3.84

1.4

213.66

160.94

pmol/l

1.00

791

5467

Disorders of lacrimal system

705

5967

1.17

3.84

1.4

98.79

161.91

pmol/l

5.62

686

5826

Other disorders of lacrimal gland

590

5011

1.18

3.81

1.3

1.4

97.33

169.14

pmol/l

5.44

573

4891

Carcinoma in situ of other and unspecified digestive organs

259

1.84

3.74

1.3

1.6

173.14

295.11

pmol/l

0.67

253

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1255

8725

1.12

3.74

1.4

102.46

133.99

pmol/l

3.43

1215

8506

Fibromyalgia

202

1531

1.33

3.73

1.4

92.84

124.83

pmol/l

1.03

194

1498

Other pulmonary diagnosis

1135

5033

1.13

3.71

1.5

1.4

157.84

118.40

pmol/l

1.49

1100

4923

Obesity related asthma

475

3970

1.20

3.69

1.5

1.4

125.01

141.27

pmol/l

0.40

463

3872

Aplastic and other anaemias

473

3609

1.20

3.69

1.6

1.4

212.20

192.16

pmol/l

0.33

459

3516

Benign thyroid growths and nodules

555

4369

1.19

3.68

1.5

1.4

116.42

163.19

pmol/l

2.58

543

4267

Symptoms and signs involving the skin and subcutaneous tissue

1025

8564

1.13

3.68

1.4

124.35

133.95

pmol/l

0.31

1002

8350

Vascular dementia

443

0.43

3.64

1.6

1.5

125.30

301.32

pmol/l

2.50

426

Benign neoplasm: Colon, unspecified

238

1849

1.29

3.61

1.4

123.92

217.54

pmol/l

3.71

231

1800

Coronary revascularization (ANGIO or CABG)

772

5391

0.87

3.60

1.4

208.86

157.56

pmol/l

0.91

758

5265

Other diseases of upper respiratory tract

1473

6912

1.11

3.58

1.5

1.4

128.12

140.75

pmol/l

0.43

1427

6744

Non-small cell lung cancer

303

1.74

3.57

1.4

162.98

89.23

pmol/l

0.99

290

COPD, early/later onset

239

2564

0.78

3.56

1.5

227.91

209.74

pmol/l

0.13

234

2499

Umbilical hernia

244

1906

1.29

3.55

1.4

144.08

135.07

pmol/l

0.10

238

1852

Disorders of conjunctiva

1254

8707

1.12

3.55

1.4

100.47

134.16

pmol/l

3.12

1229

8475

Candidiasis, including avohilmo

483

4067

1.19

3.49

1.5

108.36

143.59

pmol/l

1.23

472

3952

Percutaneous Coronary Intervention

773

5389

0.87

3.48

1.4

204.40

157.61

pmol/l

0.81

759

5263

Cough

570

4538

1.18

3.47

1.4

132.80

137.91

pmol/l

0.10

550

4431

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

382

3149

1.22

3.46

1.4

127.96

133.41

pmol/l

0.07

372

3080

Glucagon-like peptide-1 (GLP-1) analogues

382

3149

1.22

3.46

1.4

127.96

133.41

pmol/l

0.07

372

3080

Dentofacial anomalies [including malocclusion]

1147

8019

1.12

3.45

1.4

70.34

128.40

pmol/l

14.36

1118

7822

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.65

3.43

1.7

1.3

74.61

109.54

pmol/l

0.28

Injury, poisoning and certain other consequences of external causes

813

3551

1.15

3.42

1.5

1.4

138.68

138.49

pmol/l

0.00

795

3469

Disorders of other endocrine glands

619

5242

1.17

3.41

1.5

1.4

124.68

148.40

pmol/l

0.57

604

5098

Ulcerative colitis

287

2300

1.25

3.40

1.4

85.39

137.10

pmol/l

3.29

281

2242

Explicit bacterial Sepsis

675

1.48

3.40

1.4

188.87

207.71

pmol/l

0.11

657

Tonsillectomy and adenotomy

871

5328

1.14

3.39

1.4

63.50

98.07

pmol/l

5.80

843

5197

Triptan medication for migraine, min. 3 purchases

1060

7058

1.13

3.37

1.4

70.28

113.42

pmol/l

7.25

1032

6886

Disorders of synovium and tendon

790

5865

1.15

3.37

1.4

120.31

131.61

pmol/l

0.24

764

5731

Certain infectious and parasitic diseases, including avohilmo

1009

4473

1.13

3.36

1.4

151.10

124.55

pmol/l

0.70

975

4375

Asthma (only as main-diagnosis)

1009

4997

1.13

3.35

1.5

1.4

109.66

118.79

pmol/l

0.27

986

4890

Delivery

640

3908

0.86

3.35

1.4

194.30

158.61

pmol/l

0.47

622

3797

COPD, hospital admissions

238

2540

0.79

3.33

1.5

228.42

210.27

pmol/l

0.13

233

2475

Other viral diseases

362

2970

1.22

3.33

1.5

1.4

83.15

112.15

pmol/l

1.56

349

2884

Insulin medication

483

4730

0.84

3.32

1.4

169.14

139.79

pmol/l

0.86

468

4612

Injuries to the shoulder and upper arm

862

7529

0.88

3.31

1.4

132.66

144.91

pmol/l

0.38

843

7333

Asthma (only as main-diagnosis), excluding more controls

989

4843

1.13

3.30

1.5

1.4

108.72

111.74

pmol/l

0.08

967

4741

COPD differential diagnosis

1125

5027

1.12

3.30

1.4

155.61

119.02

pmol/l

1.34

1092

4920

ILD differential diagnosis

1125

5027

1.12

3.30

1.4

155.61

119.02

pmol/l

1.34

1092

4920

1637

7548

1.10

3.29

1.5

1.4

126.07

133.19

pmol/l

0.24

1590

7368

GI-bleeding

259

2059

1.26

3.28

1.6

1.4

165.42

220.20

pmol/l

1.09

250

1992

Neurological diseases

1236

5567

1.12

3.28

1.4

132.95

126.00

pmol/l

0.16

1194

5433

Pain in throat and chest

1171

6208

1.12

3.27

1.4

101.21

121.02

pmol/l

1.20

1140

6059

Symptoms and signs involving the urinary system

912

6085

1.13

3.25

1.4

147.75

156.00

pmol/l

0.16

877

5949

Purpura and other haemorrhagic conditions

150

1111

1.36

3.24

1.6

1.5

154.81

176.28

pmol/l

0.30

145

1085

Other anxiety disorders

739

5497

1.15

3.23

1.5

1.4

81.11

106.82

pmol/l

1.79

725

5351

Dermatitis

865

7484

1.13

3.20

1.4

114.85

143.28

pmol/l

1.64

835

7301

Cerebrovascular diseases

631

5048

0.86

3.19

1.5

1.4

200.45

167.01

pmol/l

0.53

618

4924

Inflammatory bowel disease

374

3104

1.21

3.19

1.3

1.5

80.58

131.28

pmol/l

4.79

364

3021

Ulcerative enterocolitis

244

1.79

3.18

1.5

62.88

184.29

pmol/l

1.12

238

Mood disorders, excluding more controls

1306

6927

1.11

3.17

1.4

112.39

133.59

pmol/l

1.16

1273

6759

Antihypertensive medication - note that there are other indications

925

4276

1.13

3.15

1.5

1.4

113.07

90.32

pmol/l

0.58

902

4159

Other viral diseases, including avohilmo

522

4423

1.17

3.13

1.4

75.66

107.76

pmol/l

3.01

506

4304

Diseases of the digestive system

468

3938

1.18

3.13

1.7

1.4

139.22

172.80

pmol/l

1.11

456

3829

Varicose veins

821

5470

1.14

3.10

1.4

212.71

147.18

pmol/l

1.32

806

5343

Premature rupture of membranes

484

2928

1.18

3.08

1.4

58.07

87.54

pmol/l

2.48

471

2855

Mycoses, including avohilmo

1263

8694

1.11

3.07

1.4

118.80

131.35

pmol/l

0.30

1230

8471

Disorders of skin appendages

711

6201

1.14

3.07

1.4

101.86

124.55

pmol/l

1.02

694

6037

Other arrhythmias

914

6065

1.13

3.05

1.4

116.45

128.62

pmol/l

0.39

881

5932

L01XX Other antineoplastic agents

377

1.61

3.04

1.6

1.5

333.68

313.12

pmol/l

0.07

369

Explicit bacterial Sepsis, including avohilmo

100

700

1.44

3.04

1.4

188.77

203.28

pmol/l

0.08

681

Ischemic heart diseases

852

5720

0.88

3.03

1.4

182.54

152.87

pmol/l

0.72

832

5586

Other intervertebral disc disorders

1120

6000

1.11

2.99

1.4

128.32

135.95

pmol/l

0.22

1088

5862

Heart failure and coronary heart disease

234

2054

0.80

2.98

1.5

315.10

225.95

pmol/l

0.70

229

1991

Coagulation defects, purpura and other haemorrhagic conditions

230

1829

1.26

2.98

1.5

134.97

148.17

pmol/l

0.26

224

1779

Sleep apnoea, including avohilmo

1375

7552

1.10

2.97

1.4

110.12

140.14

pmol/l

1.85

1336

7387

Melanocytic naevi, other sites/unspecified

114

822

1.40

2.96

1.4

1.5

89.95

159.90

pmol/l

1.00

109

806

Gastroduodenal ulcer

213

1673

1.27

2.96

1.4

1.5

248.07

212.20

pmol/l

0.22

205

1622

Missing teeth due to accident, extraction or parodontitis

744

5853

1.14

2.95

1.4

152.75

162.28

pmol/l

0.14

727

5709

401

4126

0.84

2.90

1.5

1.4

172.31

127.58

pmol/l

0.65

389

4022

Kela-code for severe mental illness

307

3716

0.82

2.90

1.4

1.5

101.36

133.16

pmol/l

1.59

296

3617

Urolithiasis

244

1960

1.25

2.89

1.5

1.4

242.16

155.30

pmol/l

0.53

239

1911

Visual disturbances and blindness

690

6063

1.14

2.87

1.4

126.92

151.72

pmol/l

0.89

670

5911

Prolonged pregnancy

233

2469

0.80

2.85

1.3

1.4

71.85

75.96

pmol/l

0.11

228

2407

Primary ovarian failure

292

1.69

2.85

1.6

1.4

68.29

135.70

pmol/l

0.90

284

Chronic laryngitis and laryngotracheitis

186

1451

1.29

2.85

1.4

97.68

162.05

pmol/l

2.47

177

1423

Asthma, excluding more controls

1051

4843

1.12

2.83

1.5

1.4

131.07

111.74

pmol/l

0.44

1026

4741

Chronic gastritis

301

2481

1.22

2.81

1.5

171.43

195.72

pmol/l

0.34

292

2414

Other gastritis (incl. Duodenitis)

232

1861

1.25

2.80

1.4

1.5

211.44

188.30

pmol/l

0.12

227

1803

COPD related to multimorbidity

186

2003

0.78

2.80

1.5

243.59

220.20

pmol/l

0.13

181

1945

Nontoxic goitre/thyroid nodule

476

4092

1.17

2.78

1.5

1.4

114.13

180.82

pmol/l

3.93

467

3990

Obesity, other/unspecified

533

4622

1.16

2.76

1.4

130.24

118.85

pmol/l

0.16

513

4514

Non-small cell lung cancer, adenocarcinoma

232

1.74

2.76

1.4

1.5

167.28

92.02

pmol/l

0.71

222

Acute pancreatitis

172

1334

1.29

2.75

1.4

1.5

158.50

185.33

pmol/l

0.28

167

1308

Chronic apical periodontitis

1550

7970

1.09

2.74

1.4

140.51

126.67

pmol/l

0.47

1506

7767

Visual impairment including blindness (binocular or monocular)

534

1.47

2.72

1.4

1.5

243.48

213.45

pmol/l

0.14

518

Asthma

1075

4997

1.11

2.70

1.5

1.4

130.01

118.79

pmol/l

0.23

1049

4890

Sequelae of cerebrovascular disease

205

2194

0.80

2.69

1.5

230.53

222.97

pmol/l

0.06

199

2132

Peripheral artery operations in Hilmo

534

0.56

2.65

1.5

297.47

260.28

pmol/l

0.08

518

Chronic kidney disease

226

1750

1.25

2.64

1.7

1.4

379.35

228.23

pmol/l

1.59

212

1703

Other and unspecified dermatitis

742

6598

1.13

2.63

1.4

108.04

145.92

pmol/l

2.69

717

6438

Acute pancreatitis (for exclusion)

172

1343

1.29

2.63

1.4

1.5

158.50

172.29

pmol/l

0.13

167

1315

Other viral diseases, not elsewhere classified

214

1711

1.25

2.62

1.5

87.45

133.88

pmol/l

1.71

207

1668

Oral corticosteroids

1459

7851

1.09

2.57

1.4

144.63

128.78

pmol/l

0.50

1427

7653

Exposure to other specified electric current

195

0.35

2.55

1.7

1.4

40.14

140.39

pmol/l

—

190

All pneumoniae

1203

8555

0.91

2.54

1.5

1.4

155.64

125.26

pmol/l

0.94

1174

8338

Type 1 diabetes, strict (exclude DM2)

747

0.64

2.54

1.4

73.88

99.50

pmol/l

0.62

727

Fibrosis and cirrhosis of liver

584

1.43

2.53

1.4

1.5

127.73

231.57

pmol/l

1.80

569

Unspecified mental disorder

370

4342

0.85

2.52

1.4

1.5

97.00

127.66

pmol/l

1.82

359

4233

Presence of other devices

244

1962

1.23

2.52

1.5

1.4

189.29

207.58

pmol/l

0.12

234

1914

Other disorders of skin and subcutaneous tissue, not elsewhere classified

160

1247

1.29

2.51

1.5

124.02

181.72

pmol/l

1.35

155

1220

Other headache syndromes

688

6092

1.13

2.50

1.4

99.21

137.39

pmol/l

1.55

670

5951

Radiculopathy

177

1398

1.27

2.49

1.4

143.68

211.87

pmol/l

1.50

170

1356

Polyarthrosis

319

2413

1.20

2.47

1.5

185.25

188.99

pmol/l

0.03

312

2351

Dislocation, sprain and strain of joints and ligaments of knee

691

7011

0.89

2.46

1.3

1.4

95.53

122.23

pmol/l

1.77

662

6853

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1167

8496

0.91

2.43

1.5

1.4

158.62

126.14

pmol/l

1.00

1141

8281

Nephropathy related operations

639

1.40

2.42

1.7

1.5

464.76

211.74

pmol/l

3.06

626

Cutaneous abscess, furuncle and carbuncle

291

2432

1.20

2.41

1.5

1.4

165.97

133.01

pmol/l

0.22

283

2371

Acute upper respiratory infections of multiple and unspecified sites

1089

7233

1.10

2.40

1.5

1.4

110.40

134.18

pmol/l

1.17

1055

7059

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

6.48

2.39

1.4

1.1

156.24

61.68

pmol/l

—

Migraine without aura

379

3245

1.17

2.39

1.4

59.91

108.55

pmol/l

6.20

368

3171

Calculus of kidney and ureter

229

1871

1.23

2.39

1.5

1.4

253.94

157.18

pmol/l

0.57

224

1826

Tongue abnormality

575

1.42

2.38

1.4

1.5

136.83

231.38

pmol/l

1.20

560

Other benign neoplasms of skin

467

4063

1.15

2.37

1.5

1.4

136.24

165.93

pmol/l

0.65

459

3958

Gout, idiopatic and unspecified

125

950

1.32

2.36

1.6

1.5

291.97

228.58

pmol/l

0.26

125

920

Other other unspecified disorders of the circulatory system

283

1.61

2.36

1.4

1.5

144.02

287.35

pmol/l

1.04

277

Glucosamine medication

552

3872

1.14

2.34

1.4

1.5

217.16

201.15

pmol/l

0.14

537

3777

Substance abuse, excluding more controls

444

4271

0.87

2.34

1.5

1.4

134.89

122.01

pmol/l

0.22

435

4162

Other joint disorders

1210

5769

1.10

2.33

1.4

107.62

115.99

pmol/l

0.26

1173

5618

Type 1 diabetes, definitions combined

755

0.66

2.33

1.4

72.80

100.87

pmol/l

0.72

735

Soft tissue disorders

1365

6426

1.09

2.32

1.5

1.4

133.03

124.78

pmol/l

0.21

1316

6269

Pneumonias (Asthma/COPD co-morbidities)

1200

8534

0.92

2.30

1.5

1.4

155.79

125.27

pmol/l

0.95

1171

8318

Gout, strict definition

578

1.41

2.29

1.5

389.59

249.78

pmol/l

0.41

561

Other disorders of kidney and ureter

119

905

1.32

2.27

1.7

1.5

202.83

208.53

pmol/l

0.05

114

883

Pneumothorax

317

1.55

2.27

1.5

180.82

236.93

pmol/l

0.31

310

L01XE Protein kinase inhibitors

358

1.52

2.26

1.4

1.5

116.61

255.59

pmol/l

1.87

352

Abnormal serum enzyme levels

123

906

1.31

2.25

1.4

1.5

116.98

185.72

pmol/l

1.20

123

886

Acute bronchitis

463

3963

1.15

2.25

1.5

1.4

151.05

159.27

pmol/l

0.09

449

3857

Diarrhoea and gastroenteritis of presumed infectious origin

909

7362

1.10

2.24

1.4

137.60

128.41

pmol/l

0.18

871

7179

Codes for special purposes

672

5954

1.12

2.24

1.5

1.4

159.99

135.81

pmol/l

0.53

658

5790

Other viral diseases, not elsewhere classified, including avohilmo

351

2985

1.17

2.24

1.5

75.82

112.01

pmol/l

2.44

343

2901

Provisional assignment of new diseases of uncertain etiology

671

5947

1.12

2.23

1.5

1.4

160.09

135.92

pmol/l

0.53

657

5783

Transient ischemic attack

414

3798

0.87

2.21

1.5

1.4

192.81

187.62

pmol/l

0.05

399

3708

Iron deficiency anaemia secondary to blood loss (chronic)

175

1404

1.25

2.21

1.5

1.4

171.04

171.39

pmol/l

0.00

169

1362

Other CVD

165

1317

1.26

2.17

1.4

1.5

190.85

234.69

pmol/l

0.49

160

1275

Crohn's disease of small intestine

629

1.38

2.15

1.3

1.5

70.90

155.84

pmol/l

2.14

615

Molar incisor enamel hypoplasia, with caries

4.31

2.14

1.7

1.0

469.83

43.71

pmol/l

—

Sub-endpoint used in defining T1D endpoints

181

2193

0.81

2.14

1.4

1.5

184.81

136.99

pmol/l

0.77

174

2134

Abnormal findings on examination of blood, without diagnosis

366

2852

1.16

2.13

1.5

190.11

166.46

pmol/l

0.21

356

2771

Use of hypnotics and sedatives

1415

7484

1.08

2.11

1.4

138.32

129.27

pmol/l

0.25

1378

7314

Asthma, including avohilmo

1584

8107

1.08

2.09

1.4

136.42

129.08

pmol/l

0.18

1544

7894

Other neurological diseases

698

6012

0.90

2.09

1.5

1.4

169.05

155.82

pmol/l

0.19

674

5870

Hypo-osmolality and hyponatraemia

187

1509

1.23

2.09

1.6

1.4

350.17

208.82

pmol/l

0.79

178

1473

376

3870

0.87

2.07

1.5

1.4

176.47

129.73

pmol/l

0.63

364

3771

Other benign neoplasm of uterus: Other parts/unspecified

424

1.46

2.07

1.5

101.78

308.60

pmol/l

3.95

409

Sciatica+with lumbago

716

5712

1.11

2.06

1.5

1.4

110.47

140.08

pmol/l

0.64

688

5581

Scar conditions and fibrosis of skin

466

1.43

2.06

1.5

1.4

66.80

180.04

pmol/l

2.18

460

Migraine without aura and triptan purchases

311

2661

1.18

2.05

1.4

1.5

58.05

99.85

pmol/l

3.98

301

2601

Infections with a predominantly sexual mode of transmission

480

4226

1.14

2.04

1.4

78.11

105.33

pmol/l

2.37

464

4118

Zoster [herpes zoster], including avohilmo

668

5802

1.11

2.00

1.5

1.4

110.52

165.15

pmol/l

5.75

644

5667

Visual disturbances

634

5695

1.12

1.99

1.4

112.95

150.55

pmol/l

1.86

619

5548

Other disorders of breast

269

2283

1.19

1.98

1.4

1.5

91.28

149.97

pmol/l

3.26

264

2224

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

321

3724

0.86

1.98

1.4

1.5

70.71

105.47

pmol/l

3.80

314

3622

Systemic connective tissue disorders

491

4349

1.13

1.98

1.5

1.4

122.92

166.13

pmol/l

1.77

480

4240

Type 1 diabetes

169

2071

0.81

1.96

1.4

174.41

122.07

pmol/l

0.85

164

2015

Cervicalgia

282

2402

1.18

1.96

1.4

123.42

176.05

pmol/l

0.97

274

2333

Urticaria and erythema

539

4804

1.13

1.95

1.4

1.5

109.12

132.38

pmol/l

0.83

522

4684

Melanocytic naevi

426

3744

1.14

1.94

1.5

1.4

79.56

131.89

pmol/l

4.01

416

3646

Otitis externa

275

2341

1.18

1.93

1.4

146.23

141.79

pmol/l

0.05

265

2282

Multiple myeloma, including Hilmo

157

1.73

1.93

1.4

313.77

90.70

pmol/l

0.67

151

Other and unspecified injuries of ankle and foot

397

1.45

1.92

1.3

1.4

79.56

148.92

pmol/l

0.91

386

Other specified/unspecified hearing loss

701

0.68

1.92

1.4

1.5

226.26

194.14

pmol/l

0.15

686

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

100

763

1.32

1.91

1.7

1.6

167.10

218.67

pmol/l

0.69

747

Other predominantly sexually transmitted diseases, not elsewhere classified

263

2234

1.18

1.91

1.3

1.5

75.15

110.20

pmol/l

1.82

255

2180

Hard cardiovascular diseases

915

5900

0.91

1.89

1.5

1.4

173.06

145.08

pmol/l

0.74

899

5760

Dialysis, with operation codes

670

1.33

1.88

1.7

1.5

462.85

215.54

pmol/l

3.02

656

COPD/asthma/ILD related infections

1486

6934

1.07

1.88

1.5

1.4

123.97

129.39

pmol/l

0.14

1447

6770

COPD/asthma related infections

1486

6934

1.07

1.88

1.5

1.4

123.97

129.39

pmol/l

0.14

1447

6770

Implicit viral Sepsis, including avohilmo

322

2776

1.16

1.87

1.5

1.4

139.29

189.40

pmol/l

1.60

306

2693

Other symptoms and signs involving cognitive functions and awareness

403

4062

0.88

1.87

1.4

150.24

177.19

pmol/l

0.59

390

3959

Nonorganic sleeping disorders, excluding more controls

290

2488

1.17

1.86

1.4

77.13

113.79

pmol/l

2.24

282

2420

IBD patients in KELA-register

257

2183

1.18

1.86

1.4

65.94

130.11

pmol/l

5.69

250

2127

Diseases of appendix

966

7940

1.09

1.85

1.4

97.99

127.00

pmol/l

1.84

938

7758

Used for control exclusion in common control thyroid runs

1329

6221

1.08

1.85

1.4

130.58

119.63

pmol/l

0.28

1293

6061

Inflammatory bowel disease, strict (require KELA)

257

2185

1.18

1.85

1.4

1.5

65.94

124.50

pmol/l

5.19

250

2130

Heart failure and antihypertensive medication

241

1317

1.19

1.84

1.5

1.4

352.04

153.87

pmol/l

1.41

232

1286

Alzheimer’s disease (Early onset), excluding more controls

273

0.51

1.84

1.5

1.6

107.20

272.31

pmol/l

2.41

265

Gastric ulcer

146

1176

1.25

1.83

1.4

1.5

249.20

205.51

pmol/l

0.19

138

1142

Intestinal infectious diseases

1247

8607

1.08

1.83

1.4

136.32

129.42

pmol/l

0.17

1201

8394

Bronchitis

1505

8429

1.07

1.83

1.5

1.4

130.80

130.48

pmol/l

0.01

1455

8224

Seborrhoeic keratosis

293

2522

1.17

1.81

1.4

106.60

208.84

pmol/l

5.08

283

2467

Carpal tunnel syndrome

883

7016

1.09

1.81

1.4

161.91

143.54

pmol/l

0.28

865

6858

Ectopic pregnancy

343

2991

1.15

1.81

1.4

109.78

125.19

pmol/l

0.29

336

2934

194

1503

1.21

1.81

1.4

1.5

202.14

277.27

pmol/l

1.19

183

1457

Familial hypercholesterolemia

116

912

1.28

1.79

1.8

1.5

227.31

219.77

pmol/l

0.05

111

887

Caries of enamel

1335

8132

1.07

1.79

1.4

90.49

136.08

pmol/l

4.45

1305

7928

Type 1 diabetes, wide definition

153

1872

0.81

1.78

1.4

160.68

120.24

pmol/l

0.57

147

1822

Unspecified haematuria

303

2129

1.16

1.76

1.4

1.5

180.16

200.24

pmol/l

0.19

291

2074

Disorders of breast

1027

8359

1.08

1.75

1.4

137.15

134.19

pmol/l

0.05

1001

8159

ILD medications: prednisolone, methylprednisolone, prednisone

1468

7623

1.07

1.75

1.4

134.11

127.32

pmol/l

0.20

1436

7429

Retention of urine

204

1379

1.20

1.73

1.5

186.49

167.17

pmol/l

0.14

198

1337

Nerve, nerve root and plexus disorders

1427

8006

1.07

1.73

1.4

138.08

132.03

pmol/l

0.13

1393

7816

Type 1 diabetes, strict definition

601

0.68

1.73

1.4

68.34

84.14

pmol/l

0.29

585

Type 1 diabetes, strict definition, subgroup 1

565

0.67

1.72

1.5

1.4

70.34

85.69

pmol/l

0.26

549

HSIL lesion of the cervix uteri, vagina or vulva

409

3623

1.13

1.72

1.4

1.5

83.30

100.35

pmol/l

0.59

403

3534

Delivery, wide proxy

542

3200

0.90

1.70

1.4

210.82

166.29

pmol/l

0.52

523

3106

Gout, unspecified

743

1.30

1.69

1.4

1.5

300.78

254.08

pmol/l

0.14

717

Osteopathies and chondropathies

734

6126

1.10

1.69

1.4

138.49

157.79

pmol/l

0.69

714

5973

Follicular adenocarcinoma of thyroid gland

2.56

1.68

2.0

1.3

53.60

62.13

pmol/l

—

Diseases of pulp and periapical tissues and dental caries

803

3763

1.10

1.68

1.5

1.4

163.03

152.24

pmol/l

0.17

782

3663

Implicit viral Sepsis

196

1644

1.20

1.68

1.5

1.4

154.82

194.64

pmol/l

0.73

186

1592

Hypokalaemia

140

1137

1.24

1.67

1.6

1.5

156.70

168.87

pmol/l

0.18

135

1109

Viral and other specified intestinal infections

218

1802

1.18

1.66

1.5

71.31

120.85

pmol/l

3.01

206

1747

Vascular dementia (subcortical)

164

0.42

1.66

1.4

82.43

409.02

pmol/l

—

159

Isolated growth hormone deficiency

2.85

1.66

2.3

1.5

91.29

51.56

pmol/l

—

Nontoxic multinodular goitre

301

2619

1.15

1.66

1.5

1.4

129.34

188.10

pmol/l

1.80

295

2551

Migraine with aura, drug-induced

130

0.38

1.65

1.2

1.4

66.40

232.16

pmol/l

—

125

Personal history of malignant neoplasm

145

1185

1.23

1.65

1.4

102.33

170.62

pmol/l

2.04

138

1167

Haemorrhage from respiratory passages

325

2512

1.15

1.65

1.5

1.4

243.91

176.76

pmol/l

0.54

314

2455

Complications of other internal prosthetic devices, implants and grafts

310

1.46

1.64

1.8

1.4

103.82

216.34

pmol/l

1.65

303

Other obstructive and reflux uropathy

352

1.43

1.63

1.9

1.3

285.65

122.90

pmol/l

0.83

343

Gonarthrosis, primary, with knee surgery

638

4510

1.10

1.63

1.4

266.63

168.02

pmol/l

1.28

624

4404

Rheumatoid arthritis, including avohilmo

412

4625

0.89

1.61

1.4

187.32

163.96

pmol/l

0.26

403

4509

Diseases of pulp and periapical tissues, including avohilmo

1395

6750

1.07

1.61

1.4

140.54

129.80

pmol/l

0.29

1355

6574

Viral Sepsis

196

1651

1.19

1.61

1.5

1.4

154.82

194.06

pmol/l

0.72

186

1599

All dysplastic lesions of the cervix uteri, vagina or vulva

613

5437

1.10

1.61

1.4

78.75

101.50

pmol/l

1.46

605

5300

Hypertrichosis

321

1.46

1.60

1.4

1.3

55.61

133.21

pmol/l

1.26

311

Anuria and oliguria

2.38

1.60

1.3

1.5

133.40

79.53

pmol/l

—

Certolizumab pegol

235

0.50

1.60

1.6

1.4

66.08

154.98

pmol/l

0.99

227

Subjective visual disturbances

343

3022

1.14

1.58

1.3

1.5

108.75

160.19

pmol/l

1.61

331

2936

Type 1 diabetes, wide definition, subgroup 1

147

1779

0.82

1.58

1.5

1.4

163.90

118.79

pmol/l

0.63

141

1732

Statin medication

873

5325

0.92

1.57

1.4

166.29

111.01

pmol/l

1.39

849

5216

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1058

7241

1.08

1.57

1.4

82.39

118.87

pmol/l

3.58

1030

7068

Other acute lower respiratory infections

586

5066

1.10

1.56

1.5

1.4

139.12

146.55

pmol/l

0.10

567

4927

Nonorganic sleeping disorders

290

2529

1.15

1.56

1.4

1.5

77.13

119.59

pmol/l

2.79

282

2465

Other and unspecified urticaria

277

2411

1.15

1.54

1.3

1.4

104.89

133.02

pmol/l

0.65

269

2349

Other disorders of bladder

640

1.30

1.54

1.5

100.18

181.12

pmol/l

2.14

625

Diseases of the respiratory system

936

4337

1.08

1.53

1.5

1.4

171.32

124.29

pmol/l

1.51

910

4248

Infections with a predominantly sexual mode of transmission, including avohilmo

614

5119

1.10

1.52

1.4

71.99

98.62

pmol/l

3.22

590

4987

Periodontal disease, other/unspecified

258

1.49

1.52

1.4

1.6

103.21

225.26

pmol/l

1.09

251

Adrenocortical insufficiency

341

1.42

1.52

1.4

81.36

225.36

pmol/l

1.97

334

Obstructed labour due to malposition and malpresentation of fetus

380

3947

0.89

1.51

1.4

89.76

91.76

pmol/l

0.02

369

3862

Dental pulpitis, including avohilmo

1266

7592

1.07

1.50

1.4

114.65

119.35

pmol/l

0.11

1225

7406

Carcinoma in situ of cervix uteri

195

1658

1.18

1.49

1.4

1.5

80.17

114.31

pmol/l

0.70

190

1615

L04AD Calcineurin inhibitors

105

839

1.26

1.48

1.6

1.5

217.37

170.16

pmol/l

0.53

100

825

Ulcerative rectosigmoiditis

680

1.29

1.48

1.4

1.5

71.39

136.09

pmol/l

1.67

666

Presence of cardiac and vascular implants and grafts

231

1971

0.86

1.47

1.5

1.4

179.42

230.79

pmol/l

0.81

224

1920

Acute suppurative otitis media

324

2666

1.14

1.45

1.4

1.5

71.42

95.53

pmol/l

1.13

304

2594

Other arthrosis

635

3888

1.10

1.44

1.3

1.4

142.18

147.81

pmol/l

0.13

616

3803

Schizophrenia or delusion, excluding more controls

270

3046

0.87

1.44

1.5

1.4

122.75

132.90

pmol/l

0.24

261

2966

Benign neoplasm: Sigmoid colon

170

1432

1.19

1.44

1.3

1.5

139.89

207.87

pmol/l

1.18

164

1394

Other and unspecified abdominal hernia

328

1.41

1.44

1.3

1.4

224.54

239.81

pmol/l

0.04

320

Superficial injury of forearm

119

969

1.23

1.43

1.4

1.5

110.79

138.55

pmol/l

0.32

114

945

Autoimmune diseases

1421

6784

1.06

1.43

1.4

134.46

120.78

pmol/l

0.38

1379

6609

Hirsutism in women

296

1.44

1.42

1.5

1.3

48.64

120.94

pmol/l

1.20

287

Other inflammatory liver diseases

552

1.31

1.42

1.4

1.5

107.06

209.12

pmol/l

1.85

539

Acute appendicitis, no complications

704

6445

1.09

1.41

1.4

106.19

117.71

pmol/l

0.35

683

6301

Other problems related to primary support group, including family circumstances

157

1281

1.20

1.40

1.4

1.5

65.24

117.80

pmol/l

2.06

152

1250

Appendicitis, broad definition

946

7904

1.07

1.40

1.4

98.80

126.98

pmol/l

1.71

918

7724

Pneumonia, organism unspecified

1081

7915

0.93

1.40

1.5

1.4

169.59

129.78

pmol/l

1.09

1058

7717

HSIL lesion of the cervix uteri

371

3319

1.12

1.39

1.4

1.5

81.16

97.85

pmol/l

0.52

365

3240

Urticaria

439

3960

1.11

1.39

1.4

1.5

105.18

127.36

pmol/l

0.69

424

3859

Suicide or other Intentional self-harm

225

2595

0.86

1.39

1.4

79.83

124.84

pmol/l

3.34

220

2531

Left ventricular outflow tract obstruction, narrow definition

255

1.46

1.38

1.2

1.4

74.48

161.83

pmol/l

1.06

248

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

357

3186

1.12

1.37

1.4

1.5

84.48

117.03

pmol/l

2.18

345

3100

Perforation of tympanic membrane

106

858

1.24

1.36

1.5

127.05

182.14

pmol/l

0.66

101

837

Antenatal screening

364

2281

0.89

1.36

1.4

63.07

81.71

pmol/l

0.81

354

2226

Bitten or struck by other mammals

159

1341

1.19

1.36

1.5

83.10

131.60

pmol/l

1.18

150

1306

Injury of intra-abdominal organs

159

1.59

1.35

1.8

1.3

80.64

261.28

pmol/l

1.02

154

Caries of dentine, including avohilmo

971

4622

1.07

1.35

1.5

1.4

154.17

144.72

pmol/l

0.17

942

4501

Atopic dermatitis

899

6664

1.08

1.35

1.4

86.13

123.65

pmol/l

2.06

873

6505

Schizophrenia, schizotypal and delusional disorders

271

3079

0.88

1.35

1.5

1.4

123.96

131.74

pmol/l

0.18

262

3000

Polyneuropathies and other disorders of the peripheral nervous system

165

1397

1.18

1.34

1.6

1.5

157.27

185.49

pmol/l

0.32

160

1362

Shoulder lesions

967

5402

1.07

1.34

1.5

1.4

132.92

138.87

pmol/l

0.18

943

5284

Other specified/unspecified disorders of bone/cartilage

195

0.51

1.34

1.8

1.3

165.30

259.00

pmol/l

—

190

Insulin, combination of fast acting with intermediate-acting or long-acting

483

4816

0.91

1.33

1.4

1.5

169.14

154.81

pmol/l

0.31

468

4691

Idiopathic gout

282

1.42

1.33

2.0

1.5

235.75

306.86

pmol/l

0.31

276

Inflammatory bowel disease treatment related agents

1523

7987

1.06

1.33

1.4

127.78

127.32

pmol/l

0.01

1490

7781

Diseases of the musculoskeletal system and connective tissue

724

3346

1.09

1.33

1.4

159.47

117.39

pmol/l

0.76

705

3261

Fitting and adjustment of other devices

332

2601

1.13

1.33

1.6

1.4

202.70

138.78

pmol/l

0.78

319

2549

Deforming dorsopathies

378

3392

1.12

1.32

1.4

143.45

162.36

pmol/l

0.26

372

3304

Use of glatiramer acetate

219

0.54

1.32

1.3

1.4

82.32

128.57

pmol/l

0.38

212

Diseases of salivary glands

435

3937

1.11

1.31

1.4

111.28

151.19

pmol/l

1.58

420

3836

All influenza

243

2123

1.15

1.31

1.7

1.4

180.79

164.41

pmol/l

0.13

231

2063

Disturbances of skin sensation

401

3616

1.11

1.30

1.4

104.75

126.27

pmol/l

0.53

394

3526

Generalized anxiety disorder

241

2105

1.15

1.30

1.4

1.5

71.71

106.93

pmol/l

1.57

235

2038

Schizophrenia or delusion

270

3059

0.88

1.30

1.5

1.4

122.75

132.13

pmol/l

0.23

261

2980

Haemorrhage in early pregnancy

568

5062

1.09

1.29

1.4

88.40

116.34

pmol/l

1.66

554

4949

Aggressive periodontitis

176

0.51

1.29

1.7

1.4

1233.56

187.83

pmol/l

—

170

Malignant neoplasm of accessory sinuses, including Hilmo

2.83

1.29

1.0

1.3

61.80

60.58

pmol/l

—

Alcohol use disorder, Swedish definition

349

3539

0.89

1.29

1.5

1.4

160.42

127.27

pmol/l

0.54

337

3449

L04AX Other immunosuppressants

643

6958

0.92

1.28

1.4

131.23

140.85

pmol/l

0.17

623

6802

Other and unspecified disorders of white blood cells

294

1.40

1.27

1.6

1.5

104.05

227.13

pmol/l

1.31

289

Dislocation, sprain and strain of joints and ligaments at neck level

194

1674

1.16

1.27

1.4

1.5

71.20

119.30

pmol/l

2.35

188

1632

5-aminosalicylic acid

241

2112

1.14

1.27

1.4

65.94

126.59

pmol/l

5.74

236

2055

Open bite that required surgery (Lefort1 or BSSO)

118

0.42

1.27

1.4

1.3

32.54

69.14

pmol/l

—

113

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

459

0.69

1.26

1.4

71.13

115.19

pmol/l

0.85

444

Seropositive rheumatoid arthritis

278

3116

0.88

1.25

1.5

1.4

206.13

161.39

pmol/l

0.39

273

3043

Extrapyramidal and movement disorders

348

3871

0.90

1.24

1.4

156.70

176.25

pmol/l

0.14

338

3771

Pustulosis palmaris et plantaris

467

0.70

1.23

1.4

1.6

109.94

216.68

pmol/l

1.34

457

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

2.68

1.22

1.6

1.4

76.50

77.74

pmol/l

—

Spondylosis

640

4618

1.08

1.21

1.4

165.21

160.26

pmol/l

0.05

622

4516

Endovascular or surgical operations to intracerebral aneurysms

547

0.73

1.21

1.2

1.6

93.12

243.57

pmol/l

3.00

535

Actinomycosis

2.36

1.20

3.0

1.4

83.50

98.44

pmol/l

—

Candidiasis

191

1656

1.16

1.19

1.7

1.5

144.39

152.40

pmol/l

0.07

184

1614

Acute appendicitis

881

7652

1.07

1.18

1.4

98.43

126.17

pmol/l

1.55

857

7477

Conjunctivitis

1143

8678

1.06

1.18

1.4

99.49

133.32

pmol/l

2.98

1119

8446

Other and unspecified nonorganic psychotic disorders

160

1864

0.86

1.18

1.5

87.65

127.94

pmol/l

1.60

154

1817

Sleep apnoea

1220

7263

1.06

1.17

1.4

118.98

143.03

pmol/l

1.08

1186

7102

Hernia

1200

7529

1.06

1.17

1.5

1.4

154.17

138.97

pmol/l

0.52

1176

7348

Viral and other specified intestinal infections, including avohilmo

324

2799

1.12

1.16

1.5

1.4

121.08

108.39

pmol/l

0.10

308

2715

Disorders of vitreous body and globe

630

5515

1.08

1.16

1.5

1.4

128.35

172.36

pmol/l

2.04

616

5385

Temporomandibular joint disorders, including avohilmo

771

6968

1.07

1.16

1.4

68.76

116.60

pmol/l

9.09

749

6794

Benign neoplasm of bone and articular cartilage

795

1.23

1.16

1.5

73.13

172.83

pmol/l

3.06

781

Diseases of external ear

379

3434

1.11

1.15

1.4

134.38

155.54

pmol/l

0.43

363

3344

Alzheimer’s disease (undefined), excluding more controls

0.00

1.15

0.0

1.3

—

363.41

—

Localized swelling, mass and lump of skin and subcutaneous tissue

383

3473

1.11

1.15

1.4

150.53

152.63

pmol/l

0.03

373

3383

255

1939

1.13

1.15

1.4

1.5

193.63

253.97

pmol/l

1.16

240

1888

Pilonidal cyst

571

1.27

1.15

1.5

1.4

120.36

99.40

pmol/l

0.12

557

Lichen ruber planus, wide definition including periferal and oral lichen planus

287

2564

1.12

1.15

1.4

1.5

145.88

177.88

pmol/l

0.44

282

2497

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

321

3521

0.90

1.14

1.4

70.71

103.81

pmol/l

3.57

314

3426

Pustular psoriasis

495

0.72

1.14

1.3

1.5

108.11

216.81

pmol/l

1.52

485

Necrosis of pulp, including avohilmo

761

7018

1.07

1.14

1.4

125.58

120.33

pmol/l

0.08

738

6853

Migraine with aura

429

3914

1.10

1.14

1.4

69.58

123.52

pmol/l

6.51

416

3819

Maternal care for other conditions predominantly related to pregnancy

352

3789

0.90

1.14

1.3

1.4

69.14

90.52

pmol/l

1.71

343

3700

Femoral hernia

319

0.65

1.13

1.4

1.5

71.57

253.55

pmol/l

2.53

311

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

475

4356

1.09

1.13

1.5

1.4

148.48

148.29

pmol/l

0.00

463

4253

Anankastic personality disorder

436

0.71

1.13

1.5

44.16

117.99

pmol/l

1.91

424

Second line medication for Crohn's disease

669

7180

0.93

1.13

1.4

128.58

138.86

pmol/l

0.19

648

7012

Chronic tubulo-interstitial nephritis

327

1.36

1.13

1.3

1.4

233.83

198.34

pmol/l

0.19

318

Assault by hanging, strangulation and suffocation

2.34

1.12

1.4

1.5

133.00

167.50

pmol/l

—

Diabetic retinopathy

225

1586

0.88

1.12

1.4

1.5

193.22

197.39

pmol/l

0.04

218

1543

Other diseases of hard tissues of teeth

652

3127

1.08

1.12

1.5

1.4

163.79

165.24

pmol/l

0.02

634

3057

Gestational [pregnancy-induced] hypertension

439

4783

0.91

1.12

1.3

1.4

92.67

102.07

pmol/l

0.12

427

4665

Herpesviral [herpes simplex] infections, including avohilmo

326

3611

0.90

1.11

1.4

1.5

113.58

121.68

pmol/l

0.16

318

3517

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

301

2703

1.12

1.11

1.3

1.5

72.35

101.61

pmol/l

1.75

290

2635

Phakomatoses, not elsewhere classified

104

1.66

1.11

1.5

1.4

212.12

207.25

pmol/l

0.01

Panic disorder

209

1836

1.14

1.10

1.4

1.5

67.51

112.51

pmol/l

2.72

203

1779

Intracranial trauma

693

5024

0.93

1.10

1.4

109.74

124.17

pmol/l

0.62

669

4910

Paroxysmal tachycardia

274

2030

1.12

1.10

1.4

113.75

119.49

pmol/l

0.11

264

1980

Sulfasalazine

295

3284

0.90

1.10

1.4

1.5

166.27

139.24

pmol/l

0.23

281

3200

Struck by thrown, projected or falling objec

304

0.65

1.09

1.3

1.4

66.10

147.21

pmol/l

1.13

296

Symptoms and signs involving the nervous and musculoskeletal systems

707

6595

1.07

1.09

1.4

108.67

148.66

pmol/l

2.71

683

6434

therapeutic use

227

1.42

1.08

1.7

1.5

64.97

319.03

pmol/l

2.74

222

Reimbursement for rheumatic diseases

679

7232

0.93

1.08

1.4

148.95

143.38

pmol/l

0.09

659

7066

Crohn disease

140

1196

1.17

1.08

1.3

1.5

69.17

149.94

pmol/l

3.96

135

1164

Etanercept

716

0.78

1.08

1.6

1.5

69.64

180.01

pmol/l

3.08

703

Mycoses

316

2849

1.11

1.08

1.6

1.4

187.81

149.27

pmol/l

0.26

305

2769

Erysipelas, including avohilmo

714

5663

0.93

1.07

1.5

1.4

192.73

134.44

pmol/l

1.00

694

5529

Malignant neoplasm of head and neck, including Hilmo

338

1.33

1.07

1.4

178.24

82.25

pmol/l

0.73

323

Mental and behavioural disorders due to alcohol

326

3433

0.90

1.07

1.4

170.67

123.54

pmol/l

0.56

319

3344

Myocardial infarction, with ST-elevation

581

0.76

1.07

1.6

1.5

151.60

276.03

pmol/l

1.69

563

ILD medications

1496

7682

1.05

1.04

1.4

131.91

126.71

pmol/l

0.15

1459

7482

2.32

1.04

1.6

75.40

54.57

pmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

779

1.21

1.04

1.5

140.45

205.67

pmol/l

0.61

762

Other retinal disorders

584

4773

0.93

1.03

1.4

189.51

172.06

pmol/l

0.29

562

4652

Asthma mixed form (mode), excluding more controls

485

0.74

1.03

1.5

1.4

64.35

136.53

pmol/l

1.45

475

All dysplastic lesions of the cervix uteri

528

4814

1.08

1.03

1.4

79.08

97.18

pmol/l

0.87

521

4697

Asthma, hospital admissions , main diagnosis only

1079

8887

1.06

1.02

1.5

1.4

114.36

132.28

pmol/l

0.70

1055

8653

Other/unspecified enthesopathies of lower limb, excluding foot

762

1.21

1.02

1.6

1.5

211.79

174.26

pmol/l

0.10

747

Type1 diabetes, definitions combined, early onset

483

0.74

1.02

1.5

1.4

72.86

63.69

pmol/l

0.21

470

Seropositive rheumatoid arthritis, strict definition

146

1688

0.86

1.02

1.4

227.01

166.93

pmol/l

0.29

141

1650

581

5358

1.08

1.01

1.5

1.4

133.35

132.98

pmol/l

0.01

562

5214

Toxic effect of other and unspecified substances

109

0.45

1.01

1.2

1.4

57.40

197.80

pmol/l

—

104

Asthma mixed form (mode)

483

0.74

1.00

1.5

64.35

137.81

pmol/l

1.48

472

Inguinal of femoral hernia, unilateral

213

0.61

1.00

1.4

86.62

320.74

pmol/l

2.00

208

Femoral hernia, unilateral

213

0.61

1.00

1.4

86.62

320.74

pmol/l

2.00

208

Inguinal hernia, unilateral

213

0.61

1.00

1.4

86.62

320.74

pmol/l

2.00

208

Pain in thoracic spine

208

1842

1.13

1.00

1.6

1.4

72.96

157.81

pmol/l

6.93

201

1789

Arthropathies

1203

5769

1.05

1.00

1.4

110.98

115.99

pmol/l

0.13

1166

5618

Other meningitis

157

0.57

0.99

1.9

1.4

104.89

202.06

pmol/l

—

152

Primary gonarthrosis, bilateral

573

4458

1.08

0.99

1.4

254.25

165.27

pmol/l

1.08

554

4355

Mental and behavioural disorders due to psychoactive substance use

459

4554

0.92

0.99

1.5

1.4

153.85

124.22

pmol/l

0.46

450

4437

Other cestode infections

0.00

0.99

0.0

1.4

—

227.06

—

Maternal care for known or suspected fetal abnormality and damage

264

2484

0.90

0.99

1.3

1.4

72.99

70.79

pmol/l

0.05

253

2421

Post-traumatic stress disorder

133

1143

1.17

0.99

1.4

65.67

87.48

pmol/l

0.63

124

1112

Hyperparathyroidism

220

1936

1.13

0.98

1.6

1.5

205.08

241.40

pmol/l

0.29

212

1881

Normal-pressure hydrocephalus

260

0.65

0.97

1.5

102.06

334.34

pmol/l

2.66

254

Epidural haemorrhage

1.96

0.97

1.6

1.4

114.29

351.98

pmol/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

436

4017

1.09

0.97

1.5

1.4

122.57

137.96

pmol/l

0.23

423

3930

Other/unspecified seropositive rheumatoid arthritis

272

3014

0.90

0.97

1.5

1.4

208.40

180.14

pmol/l

0.21

267

2939

Disorders of choroid and retina

807

5996

0.94

0.96

1.4

161.63

157.27

pmol/l

0.08

782

5854

Pregnancy, childbirth and the puerperium

464

2625

0.92

0.96

1.5

191.58

165.79

pmol/l

0.27

452

2545

Thyrotoxicosis, other and/or unspecified

300

2720

1.11

0.96

1.4

202.61

155.28

pmol/l

0.32

293

2648

All influenza (not pneumonia)

126

1080

1.17

0.96

1.8

1.5

222.15

166.65

pmol/l

0.26

120

1052

Spirochaetal infections, other/unspecified

832

1.19

0.96

1.4

1.5

94.37

197.72

pmol/l

2.78

813

Hyperfunction of pituitary gland

546

0.76

0.95

1.4

59.89

137.73

pmol/l

1.73

531

Other and unspecified injuries of abdomen, lower back and pelvis

133

1.52

0.95

1.2

1.3

258.98

158.61

pmol/l

0.21

128

Disease of hard tissues of teeth, NOS

637

3110

1.07

0.95

1.4

121.15

165.07

pmol/l

1.12

615

3043

Mixed connective tissue disease

197

0.60

0.95

1.5

1.3

76.50

278.19

pmol/l

1.48

192

Diseases of oral cavity, salivary glands and jaws

651

3131

1.07

0.95

1.5

1.4

169.50

165.27

pmol/l

0.05

635

3061

Burn and corrosion of head and neck

116

0.51

0.94

1.8

1.3

63.50

101.53

pmol/l

—

110

Type of accident

307

2789

1.10

0.94

1.4

145.89

159.80

pmol/l

0.21

298

2709

Influenza and pneumonia

1322

8536

0.95

0.93

1.5

1.4

149.59

124.27

pmol/l

0.81

1289

8319

Migraine with aura and triptan purchases

280

2536

1.11

0.93

1.4

1.5

71.72

108.54

pmol/l

2.34

270

2477

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

525

4820

1.08

0.93

1.5

1.4

96.69

112.70

pmol/l

0.55

508

4683

Residual foreign body in soft tissue

362

0.72

0.93

1.7

1.5

100.23

125.54

pmol/l

0.19

356

Malignant neoplasm of head and neck

252

1.35

0.91

1.4

211.53

80.80

pmol/l

0.76

239

False labour

612

3549

1.07

0.91

1.4

65.00

79.68

pmol/l

0.92

595

3464

Open wound of wrist and hand

410

3651

1.09

0.91

1.5

1.4

79.30

112.76

pmol/l

2.88

397

3547

Postpartum care and examination

228

1596

0.89

0.91

1.4

68.70

64.73

pmol/l

0.09

219

1552

Schizoaffective disorder

720

0.80

0.91

1.5

111.77

160.90

pmol/l

0.64

708

Other disorders of adrenal gland

420

1.27

0.91

1.4

81.72

201.10

pmol/l

1.98

412

Bacterial Sepsis

419

3195

1.08

0.90

1.6

1.4

229.19

188.03

pmol/l

0.74

405

3112

Bicuspidal aortic valve syndrome

185

1.41

0.89

1.2

1.4

62.38

148.21

pmol/l

0.80

180

Superficial injury of wrist and hand

246

2218

1.11

0.89

1.4

1.5

128.85

125.72

pmol/l

0.02

239

2156

Foreign body on external eye

555

1.23

0.89

1.4

84.26

160.84

pmol/l

1.23

542

Viral infections characterized by skin and mucous membrane lesions

476

4417

1.08

0.89

1.5

1.4

106.01

152.68

pmol/l

3.11

465

4299

Labour and delivery complicated by fetal stress [distress]

434

3050

0.92

0.89

1.4

57.50

65.54

pmol/l

0.48

425

2972

Paranoid personality disorder

169

0.59

0.89

1.4

52.30

152.88

pmol/l

—

164

Dental caries, including avohilmo

873

4222

1.06

0.89

1.5

1.4

159.86

149.15

pmol/l

0.19

851

4112

Malignant neoplasm of brain, including Hilmo

245

1.35

0.89

1.5

1.4

70.64

73.03

pmol/l

0.05

239

STROKE

623

4473

0.94

0.89

1.5

1.4

172.66

141.17

pmol/l

0.53

606

4368

Benign paroxysmal vertigo

380

3500

1.09

0.89

1.5

1.4

133.66

187.05

pmol/l

1.82

370

3409

Supervision of high-risk pregnancy

401

2220

1.09

0.88

1.5

1.4

80.96

83.29

pmol/l

0.05

394

2169

Other inflammation of eyelid, including avohilmo

675

6350

1.06

0.88

1.4

76.61

132.18

pmol/l

6.73

658

6196

Other disorders of white blood cells

404

1.27

0.88

1.5

96.20

210.51

pmol/l

1.71

395

Somatoform disorder

224

2013

1.12

0.87

1.4

167.65

136.03

pmol/l

0.30

216

1961

Other and unspecified injuries of shoulder and upper arm

246

1.35

0.87

1.4

98.42

269.88

pmol/l

1.42

241

Other condition

144

1259

1.15

0.87

1.4

1.5

146.68

154.87

pmol/l

0.07

139

1228

Congenital malformations of aortic and mitral valves

212

1.37

0.86

1.2

1.4

61.48

165.38

pmol/l

1.09

206

Non-ischemic cardiomyopathy

279

2010

1.10

0.85

1.5

1.4

303.22

217.88

pmol/l

0.57

273

1954

Other infectious diseases

496

1.23

0.84

1.5

324.05

209.91

pmol/l

0.31

487

Deep bite

903

0.84

1.4

1.5

84.38

155.85

pmol/l

1.04

876

Behavioural disorders, excluding more controls

137

0.58

0.83

1.1

1.4

41.38

88.48

pmol/l

—

131

Other immunodeficiencies

113

1.53

0.83

1.8

1.4

220.59

111.49

pmol/l

0.54

108

Seropositive rheumatoid arthritis, wide

278

3046

0.91

0.83

1.5

1.4

206.13

179.49

pmol/l

0.20

273

2970

LSIL lesion of the cervix uteri, vagina or vulva

271

2470

1.10

0.83

1.4

1.5

71.12

109.84

pmol/l

2.66

265

2413

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

597

5404

1.07

0.83

1.3

1.4

94.26

139.75

pmol/l

4.15

577

5294

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

272

2982

0.91

0.82

1.5

1.4

208.40

177.95

pmol/l

0.23

267

2907

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

586

3931

0.94

0.82

1.4

50.01

62.51

pmol/l

3.05

571

3819

Long labour

430

3918

0.93

0.82

1.4

88.86

96.66

pmol/l

0.15

423

3829

Disorders of vitreous body

609

5445

1.06

0.82

1.5

1.4

127.82

173.64

pmol/l

2.10

596

5317

Pacemaker

240

2019

1.11

0.81

1.4

1.5

232.91

247.05

pmol/l

0.11

231

1964

Von Willebrand disease

164

1.42

0.81

1.2

1.4

149.00

155.56

pmol/l

0.02

159

Plasmodium falciparum malaria

0.00

0.80

0.0

1.4

—

200.56

—

Plasmodium falciparum malaria, including avohilmo

0.00

0.80

0.0

1.4

—

200.56

—

Congenital malformations of nose, including avohilmo

0.00

0.80

0.0

1.3

—

201.58

—

Contact with other sharp object(s)

509

1.22

0.80

1.5

74.39

135.69

pmol/l

0.85

492

Spinal instabilities

260

1.32

0.78

1.6

83.21

198.50

pmol/l

1.26

255

Mental and behavioural disorders of puerperium, not classified elsewhere

186

0.64

0.78

1.3

1.4

74.83

83.91

pmol/l

0.14

181

Other symptoms and signs involving the nervous and musculoskeletal systems

526

4933

1.07

0.78

1.4

85.27

143.68

pmol/l

7.09

507

4816

Injuries to the wrist and hand

1248

8622

0.96

0.78

1.4

104.54

131.64

pmol/l

1.30

1211

8404

Atrial septal defect, secundum type

216

1.35

0.78

1.6

1.4

81.16

174.66

pmol/l

0.89

209

Other diseases of lip and oral mucosa

556

5227

1.07

0.77

1.4

110.17

154.77

pmol/l

2.33

541

5102

Other obstetric conditions, not elsewhere classified

602

4031

0.94

0.77

1.4

50.39

68.45

pmol/l

3.41

587

3918

Benign neoplasm: Skin of ear and external auricular canal

257

0.70

0.77

1.3

1.5

82.39

287.07

pmol/l

2.24

252

Hypotension

121

1057

1.15

0.76

1.3

1.5

208.59

226.14

pmol/l

0.13

116

1020

Routine general health check-up of defined subpopulation

235

1.33

0.76

1.4

83.61

152.96

pmol/l

0.67

229

Striking against or struck by other objects

294

2696

1.09

0.76

1.3

1.5

104.93

120.81

pmol/l

0.24

284

2620

Pregnancy examination and test

308

1754

1.09

0.76

1.3

1.4

51.96

67.51

pmol/l

1.75

299

1709

Gonarthrosis [arthrosis of knee](FG)

837

5063

0.95

0.75

1.4

188.33

137.91

pmol/l

0.92

816

4959

Other disorders of bone density and structure

245

1.32

0.74

1.3

1.4

64.71

221.88

pmol/l

1.51

238

Other systemic involvement of connective tissue

371

3447

1.08

0.74

1.5

1.4

112.23

177.50

pmol/l

3.34

364

3354

Mouth breathing

338

3123

1.08

0.74

1.4

89.77

148.24

pmol/l

4.10

328

3039

Abscess of Bartholin gland

370

1.25

0.74

1.5

1.4

80.48

121.84

pmol/l

0.57

362

Non-allergic asthma (mode)

179

1971

0.90

0.74

1.5

1.4

79.57

144.23

pmol/l

4.45

171

1924

Childhood asthma (age<16), excluding more controls

147

1018

1.13

0.73

1.4

45.51

47.01

pmol/l

0.29

140

987

Myocarditis

298

1.28

0.73

1.4

85.92

146.32

pmol/l

0.88

290

Gonarthrosis,primary

953

6015

0.95

0.73

1.4

238.55

145.12

pmol/l

1.82

928

5884

Artrosis, including avohilmo

957

5484

0.95

0.72

1.4

131.03

125.64

pmol/l

0.10

937

5361

Amputation of toe

265

0.72

1.3

1.5

404.00

322.56

pmol/l

0.11

260

Childhood asthma (age<16)

147

1020

1.13

0.72

1.4

45.51

47.01

pmol/l

0.29

140

989

Supplementary factors related to causes of morbidity and mortality classified elsewhere

326

3018

1.08

0.72

1.4

1.5

143.62

154.00

pmol/l

0.16

317

2933

Adhesive capsulitis of shoulder

199

1802

1.11

0.72

1.4

149.29

157.05

pmol/l

0.09

192

1761

Specific personality disorders

258

2811

0.92

0.71

1.5

112.66

106.75

pmol/l

0.06

252

2738

Rheumatism, unspecified

225

2052

1.10

0.71

1.5

1.4

131.72

159.92

pmol/l

0.45

220

2006

Other fibroblastic disorders

1.96

0.71

1.4

1.7

55.60

72.23

pmol/l

—

Diabetic retinopathy, excluding more controls

204

1260

0.90

0.71

1.5

1.4

184.66

165.12

pmol/l

0.23

197

1223

Disorders of vestibular function (Vertigo)

597

5496

1.06

0.71

1.5

1.4

137.61

166.38

pmol/l

0.92

585

5359

Implicit Sepsis

845

5931

1.05

0.70

1.5

1.4

183.02

146.08

pmol/l

1.25

816

5787

Other and unspecified visual disturbances

124

1094

1.14

0.70

1.5

91.16

174.63

pmol/l

2.88

124

1069

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

158

1373

1.12

0.70

1.3

1.5

122.79

147.83

pmol/l

0.47

153

1335

Flat foot [pes planus] (acquired)

109

1243

0.87

0.70

1.3

1.5

92.93

172.88

pmol/l

2.74

109

1211

All dysplastic lesions of the vagina

400

1.24

0.70

1.2

1.5

141.71

196.31

pmol/l

0.33

391

Non-allergic asthma (mode), excluding more controls

179

1964

0.90

0.70

1.5

1.4

79.57

135.19

pmol/l

4.01

171

1921

Bronchiectasis

641

0.82

0.70

1.9

1.5

125.58

221.68

pmol/l

2.00

622

Open wound of head

431

4319

0.94

0.70

1.5

143.95

165.90

pmol/l

0.37

414

4206

Nondiabetic hypoglycaemic coma

1.88

0.69

1.0

1.3

310.40

60.58

pmol/l

—

Perineal laceration during delivery

290

2533

0.92

0.69

1.3

1.5

61.70

84.79

pmol/l

0.87

278

2465

Use of fingolimod

119

0.58

0.69

1.4

34.83

87.19

pmol/l

—

113

Glomerulonephritis

648

1.18

0.68

1.5

233.92

204.94

pmol/l

0.20

637

Vocal cord dysfunction

191

1523

1.11

0.68

1.3

1.5

103.31

119.28

pmol/l

0.45

182

1487

Chondrocostal junction syndrome [Tietze]

411

1.22

0.67

1.4

1.5

69.44

220.67

pmol/l

2.70

401

Other/unspecified disorders of vestibular function

340

0.76

0.67

1.1

1.5

145.31

247.35

pmol/l

0.70

332

Suppurative and unspecified otitis media

437

3630

1.07

0.67

1.4

1.5

77.84

106.19

pmol/l

1.46

413

3531

Congenital iodine-deficiency syndrome/hypothyroidism

285

1.27

0.67

1.6

1.4

199.16

287.17

pmol/l

0.33

280

Other (seronegative) rheumatoid arthritis, wide

187

2059

0.91

0.67

1.5

1.4

168.05

187.44

pmol/l

0.21

181

2010

Postprocedural disorders of nervous system

100

874

1.15

0.67

1.4

51.77

108.54

pmol/l

2.31

855

Viral haemorrhagic fevers, not elsewhere classified/unspecified

530

1.19

0.67

1.4

1.5

92.09

211.20

pmol/l

2.11

521

Other and unspecified aplastic anaemias

1.53

0.66

2.7

1.3

159.66

250.92

pmol/l

0.29

Anogenital herpesviral [herpes simplex] infection

781

1.16

0.66

1.5

1.4

66.00

108.55

pmol/l

1.03

761

Chronic sinusitis

562

5311

1.06

0.66

1.3

1.4

107.92

135.53

pmol/l

0.91

549

5202

Superficial injury of head

254

2335

1.09

0.66

1.4

122.05

189.73

pmol/l

1.75

247

2267

Macular hole

483

0.80

0.66

1.6

1.5

219.59

268.03

pmol/l

0.14

471

Budesonide

171

1546

1.11

0.66

1.4

68.76

139.68

pmol/l

5.74

166

1504

Pregnancy hypertension

763

7139

0.95

0.65

1.4

95.32

113.16

pmol/l

0.49

745

6978

Other bacterial intestinal infections, including avohilmo

248

2283

1.09

0.65

1.4

141.86

155.43

pmol/l

0.20

242

2223

Substance abuse

444

4381

0.94

0.64

1.5

1.4

134.89

125.20

pmol/l

0.16

435

4270

Other disorders of optic disc

130

0.61

0.64

1.0

1.4

75.13

188.22

pmol/l

—

125

Lateral epicondylitis

172

1559

1.11

0.64

1.5

1.4

72.49

135.01

pmol/l

5.20

167

1528

Other disorders of binocular movement

246

0.73

0.63

1.6

1.3

46.58

132.09

pmol/l

1.09

239

Anterior Iridocyclitis

209

1913

1.09

0.63

1.4

280.36

153.31

pmol/l

1.12

202

1866

Implicit bacterial Sepsis

344

2751

1.07

0.63

1.6

1.4

240.64

202.20

pmol/l

0.61

333

2683

Medical abortion

1200

6738

0.96

0.63

1.5

1.4

118.62

134.98

pmol/l

0.63

1157

6565

Nystagmus and other irregular eye movements

121

1.42

0.63

1.0

1.4

80.88

98.56

pmol/l

0.18

116

Carbimazole or st.post thyroidectomy, condition for graves disease

311

2896

1.08

0.62

1.5

1.4

136.76

152.02

pmol/l

0.17

306

2821

Other keratitis

122

1086

1.13

0.62

1.4

1.5

84.28

143.99

pmol/l

2.06

122

1059

Stomatitis and related lesions

231

2125

1.09

0.62

1.5

1.4

118.50

141.39

pmol/l

0.49

224

2064

Iron deficiency

434

1.21

0.62

1.5

1.4

51.02

94.43

pmol/l

0.99

425

Glaucoma suspect

359

3828

0.94

0.61

1.4

1.5

183.15

184.49

pmol/l

0.01

345

3733

Obstetric embolism

0.00

0.61

0.0

1.3

—

234.85

—

Lumbar disc prolapse

812

5755

1.05

0.60

1.4

112.63

139.02

pmol/l

1.40

790

5623

SLE (Finngen)

408

1.21

0.60

1.4

1.5

153.69

167.24

pmol/l

0.09

400

Chondromalacia

245

1.27

0.60

1.3

1.5

88.00

165.92

pmol/l

0.71

240

HSIL lesion of the vagina

201

1.31

0.60

1.2

1.4

184.88

148.57

pmol/l

0.11

196

Allergic conjunctivitis

862

8635

0.96

0.60

1.4

97.07

131.18

pmol/l

2.70

846

8408

Failed induction of labour

110

978

1.13

0.59

1.3

1.5

62.08

62.15

pmol/l

0.00

103

947

Postpartum hemorraghe, parous women as controls

482

3814

1.06

0.59

1.4

53.88

90.88

pmol/l

6.09

467

3726

Cleft lip

0.00

0.59

0.0

1.3

—

49.55

—

Asthma-related infections

729

6796

1.05

0.59

1.5

1.4

148.82

136.92

pmol/l

0.23

707

6619

Asthma, hospital admission 2, infections

729

6796

1.05

0.59

1.5

1.4

148.82

136.92

pmol/l

0.23

707

6619

Benign neoplasm of other and unspecified sites

255

1.26

0.58

1.8

1.5

207.03

264.31

pmol/l

0.19

250

Diabetes mellitus in pregnancy

620

4132

0.95

0.58

1.5

1.4

72.74

75.98

pmol/l

0.12

601

4043

Hyperaldosteronism

202

1.29

0.57

1.2

1.5

87.73

259.66

pmol/l

1.27

197

Disorders of porphyrin and bilirubin metabolism

1.49

0.57

2.0

1.6

72.08

248.80

pmol/l

0.72

Exposure to unspecified factor

1244

8742

0.97

0.57

1.4

117.87

131.88

pmol/l

0.56

1210

8517

Other aneurysm

247

1.26

0.56

1.5

165.35

308.11

pmol/l

0.96

241

Single delivery by caesarean section

345

2098

0.94

0.56

1.4

53.14

85.12

pmol/l

4.06

334

2044

ILD, hospital admissions 3, with pneumonia sepsis

484

0.82

0.56

1.7

1.5

344.75

285.98

pmol/l

0.17

472

Other fall from one level to another

155

1702

0.91

0.56

1.3

1.5

137.30

137.24

pmol/l

0.00

150

1652

Adverse effects, not elsewhere classified

259

2409

1.08

0.56

1.3

1.4

84.83

131.23

pmol/l

2.35

252

2348

Hydrocephalus

505

0.83

0.55

1.5

298.02

238.56

pmol/l

0.15

496

Excessive attrition of teeth

822

7814

1.04

0.55

1.4

85.13

122.75

pmol/l

4.18

796

7624

Disorders of parathyroid gland

249

2288

1.08

0.54

1.6

1.5

191.00

225.31

pmol/l

0.32

239

2227

Psychiatric diseases

1245

6029

1.03

0.54

1.4

130.85

140.51

pmol/l

0.28

1201

5888

Chronic Coagulation defects

267

1.24

0.54

1.2

1.4

119.97

121.06

pmol/l

0.01

260

Other specified/unspecified arthritis

293

3129

0.94

0.54

1.4

1.5

168.72

151.40

pmol/l

0.14

283

3049

Diaphragmatic hernia

396

3742

1.06

0.54

1.5

1.4

157.19

181.95

pmol/l

0.51

388

3643

Gingivitis and periodontal diseases

1249

6239

1.03

0.53

1.4

157.23

140.47

pmol/l

0.34

1211

6086

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1129

7361

1.04

0.53

1.5

1.4

160.85

130.90

pmol/l

1.29

1098

7178

Contact with lifting and transmission devices, not elsewhere classified

1.49

0.53

1.5

1.4

60.27

119.24

pmol/l

0.55

Implicit bacterial Sepsis, including avohilmo

393

3085

1.06

0.53

1.6

1.4

228.74

193.81

pmol/l

0.59

381

3006

Asthma and opportunity respiratory infection

382

0.81

0.53

1.6

1.5

120.74

242.26

pmol/l

1.65

372

Recurrent aphthous stomatitis , including avohilmo

164

1501

1.09

0.53

1.5

116.63

161.67

pmol/l

0.85

159

1459

Other systemic involvement of connective tissue (FG)

366

3389

1.06

0.53

1.5

1.4

112.91

150.28

pmol/l

1.68

359

3303

Coxarthrosis, primary, with hip surgery

410

4013

0.95

0.52

1.4

1.5

175.88

197.52

pmol/l

0.26

398

3913

Asthma/COPD (KELA code 203)

1254

8115

1.03

0.52

1.5

1.4

130.18

126.18

pmol/l

0.11

1225

7898

Purulent endophthalmitis

1.51

0.52

1.5

1.4

295.00

189.41

pmol/l

—

Acne, including avohilmo

287

2174

1.07

0.51

1.5

76.10

76.43

pmol/l

0.01

277

2095

Follicular lymphoma, hilmo

287

1.22

0.51

1.6

93.74

314.97

pmol/l

2.66

282

Acute sinusitis

730

6371

1.04

0.51

1.4

106.01

120.01

pmol/l

0.52

707

6222

Injuries to the knee and lower leg

1578

8288

1.03

0.51

1.4

133.80

129.90

pmol/l

0.11

1519

8096

Systemic lupus erythematosus

416

1.18

0.51

1.4

1.5

153.69

206.65

pmol/l

0.37

407

Other maternal disorders predominantly related to pregnancy

1093

7065

0.97

0.51

1.5

1.4

93.36

120.81

pmol/l

1.87

1070

6899

Arthrosis

814

4636

0.96

0.51

1.4

138.26

132.58

pmol/l

0.10

792

4531

Osteoporosis

338

2925

1.06

0.51

1.5

192.75

222.77

pmol/l

0.48

327

2852

Other disorders of veins

575

5407

1.05

0.51

1.4

146.72

140.91

pmol/l

0.08

563

5283

Viral pneumonia

990

0.89

0.51

1.5

221.50

181.47

pmol/l

0.24

967

Supervision of normal pregnancy

371

2241

0.94

0.51

1.4

46.67

81.12

pmol/l

4.90

363

2188

Heart failure,strict

421

2782

1.06

0.51

1.5

328.10

188.46

pmol/l

1.56

410

2717

Keratitis

364

3851

0.94

0.51

1.4

1.5

90.35

145.21

pmol/l

3.42

359

3746

Diseases of the ear and mastoid process

1538

7488

1.03

0.51

1.5

1.4

119.43

129.88

pmol/l

0.37

1484

7314

Psoriasis

260

2780

0.93

0.51

1.4

110.64

149.17

pmol/l

0.98

254

2704

Diseases of inner ear

653

5988

1.04

0.50

1.5

1.4

134.98

162.46

pmol/l

0.96

639

5845

Hyperprolactinaemia

422

0.83

0.50

1.4

51.06

116.55

pmol/l

1.52

414

Glaucoma

593

4817

1.05

0.50

1.4

219.64

174.66

pmol/l

0.87

572

4700

Asymmetry of jaw

155

0.70

0.49

1.0

1.4

51.73

159.34

pmol/l

0.86

150

Cysts of oral region, not elsewhere classified

437

1.17

0.48

1.6

1.5

110.93

215.02

pmol/l

1.14

429

Chronic periodontitis, complicated

554

5639

0.96

0.48

1.4

155.43

154.37

pmol/l

0.02

541

5512

Diseases of middle ear and mastoid

726

5701

1.04

0.48

1.5

1.4

95.54

118.96

pmol/l

1.08

692

5549

Other CVD (FINNGEN)

100

684

1.12

0.48

1.3

1.4

202.17

184.77

pmol/l

0.11

669

Oral lichen planus and hypothyroidism or thyroxine medication

254

1.23

0.47

1.3

1.5

88.26

243.88

pmol/l

1.58

248

Persons with potential health hazards related to communicable diseases

488

4616

1.05

0.47

1.4

93.51

97.20

pmol/l

0.10

470

4493

Allergic asthma (mode), excluding more controls

311

2862

1.06

0.47

1.4

98.67

106.89

pmol/l

0.16

304

2792

Superficial injury of hip and thigh

140

1281

1.09

0.47

1.4

1.5

113.70

179.07

pmol/l

1.32

131

1244

Tinnitus

255

2391

1.07

0.47

1.3

1.4

114.84

171.78

pmol/l

1.79

249

2334

Scabies, including avohilmo

164

1512

1.09

0.47

1.3

1.4

60.51

119.06

pmol/l

3.30

159

1471

ILD medications: immunosuppressive drugs

821

7173

1.04

0.47

1.5

1.4

134.16

131.29

pmol/l

0.05

795

6995

Injuries to the neck

248

2324

1.07

0.46

1.4

86.46

123.22

pmol/l

1.37

238

2261

Other sexually transmitted chlamydial diseases, including avohilmo

114

1034

1.10

0.46

1.4

45.23

58.78

pmol/l

1.73

102

999

Anorexia (incl.atypical)

664

0.87

0.46

1.2

1.4

48.29

127.27

pmol/l

2.38

646

Type 2 diabetes

1347

7578

1.03

0.46

1.4

170.02

120.11

pmol/l

1.47

1307

7400

Contact with other hot fluids

232

0.77

0.46

1.4

1.3

435.67

132.44

pmol/l

0.34

225

Reactive arthropathies

781

0.88

0.46

1.4

90.38

168.83

pmol/l

1.92

764

Ankyloglossia

0.60

0.46

1.6

1.4

99.32

59.15

pmol/l

—

Other and unspecified haemorrhagic conditions

138

1.31

0.46

2.4

1.4

130.06

272.54

pmol/l

0.53

133

Lesion of ulnar nerve

121

1102

1.10

0.46

1.6

1.5

239.12

166.11

pmol/l

0.29

116

1077

Symptoms and signs involving speech and voice

373

3927

0.95

0.46

1.4

173.41

158.54

pmol/l

0.16

360

3833

Mental and behavioural disorders due to opioids

254

0.78

0.46

1.7

1.3

80.80

120.03

pmol/l

0.41

248

Dental operations

666

3290

1.04

0.45

1.5

1.4

165.76

163.46

pmol/l

0.03

652

3215

Certain zoonotic bacterial diseases, including avohilmo

219

1.24

0.45

1.4

158.63

275.55

pmol/l

0.57

214

Type 2 diabetes, definitions combined

1287

7276

1.03

0.45

1.4

169.55

123.14

pmol/l

1.24

1251

7108

Chronic hepatitis, not elsewhere classified

320

1.19

0.45

1.4

1.6

119.95

236.63

pmol/l

1.17

314

Exposure to other and unspecified animate mechanical forces

319

0.81

0.45

1.5

1.4

55.12

126.69

pmol/l

1.14

310

Diseases of arteries, arterioles and capillaries (FINNGEN)

217

1396

1.07

0.45

1.5

1.4

190.35

146.71

pmol/l

0.73

207

1370

Spontaneous abortion

935

6060

1.03

0.44

1.4

125.75

122.52

pmol/l

0.07

911

5916

Fibroblastic disorders

208

1942

1.07

0.44

1.4

170.64

156.00

pmol/l

0.15

200

1895

Insulin, fast-acting or short human

274

2904

0.94

0.44

1.4

1.5

143.67

149.23

pmol/l

0.09

265

2823

Whooping cough, including avohilmo

184

1.26

0.44

1.1

1.3

155.87

139.32

pmol/l

0.05

179

Infections of genitourinary tract in pregnancy

164

1520

1.08

0.43

1.5

114.92

146.63

pmol/l

0.33

158

1486

Cervicobrachial syndrome

297

2808

1.06

0.43

1.3

1.4

108.43

157.35

pmol/l

1.44

291

2737

Balanced rearrangements and structural markers, not elsewhere classified

1.63

0.43

1.6

1.5

37.20

48.86

pmol/l

—

Conduct disorder

129

0.69

0.43

1.1

1.3

44.56

85.71

pmol/l

—

124

Other and unspecified effects of external causes

334

3169

1.06

0.43

1.4

1.5

83.44

123.72

pmol/l

2.60

322

3086

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

328

0.82

0.43

1.5

1.4

54.15

203.91

pmol/l

2.05

320

Mental and behavioural disorders associated with the puerperium

162

0.73

0.43

1.3

1.4

74.83

85.64

pmol/l

0.16

157

Type 2 diabetes, strict (exclude DM1)

1290

7301

1.03

0.43

1.4

171.48

123.56

pmol/l

1.30

1254

7133

Blood alcohol or alcohol intoxication level

151

0.73

0.43

1.4

52.82

92.13

pmol/l

0.86

146

Gilbert syndrome

1.44

0.43

1.5

78.38

311.33

pmol/l

—

Melanocytic naevi of lower limb, including hip

471

1.15

0.43

1.4

81.15

184.42

pmol/l

1.61

460

Idiopathic pulmonary fibrosis

339

0.82

0.43

2.4

1.5

152.75

311.81

pmol/l

1.90

332

Biliary cirrhosis, NAS

1.59

0.43

1.8

1.3

221.60

89.79

pmol/l

—

Voice disturbances

311

3281

0.95

0.42

1.4

189.79

150.61

pmol/l

0.41

300

3195

Specific development disorders of scholastic skills

289

0.81

0.42

2.0

1.4

50.23

65.76

pmol/l

0.53

276

Crystalline deposits in vitreous body

1.41

0.42

1.6

1.5

148.34

266.16

pmol/l

—

Cervical disc disorders

392

3738

1.05

0.42

1.5

1.4

141.37

164.97

pmol/l

0.34

382

3655

General autosomal fish scale disease

0.00

0.42

0.0

1.6

—

65.00

—

Medullary cystic kidney disease, nephronophthisis

0.00

0.41

0.0

1.2

—

66.65

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

420

3954

1.05

0.41

1.3

1.5

128.38

168.93

pmol/l

1.28

408

3840

Fetus and newborn affected by other complications of labour and delivery

0.00

0.41

0.0

1.5

—

44.00

—

Other protozoal intestinal diseases, including avohilmo

217

0.78

0.41

1.4

106.59

156.43

pmol/l

0.25

210

Other abnormal products of conception

626

4262

0.96

0.41

1.4

68.12

91.93

pmol/l

1.49

612

4169

Allergic asthma (mode)

311

2878

1.06

0.41

1.4

98.67

105.71

pmol/l

0.13

304

2804

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

838

8278

0.97

0.41

1.4

96.22

132.72

pmol/l

2.95

823

8063

Congenital malformations of nose

0.00

0.41

0.0

1.3

—

271.86

—

Congenital myopathies

0.00

0.41

0.0

1.8

—

48.39

—

Other specified and unspecified disorders of lens

1.36

0.41

1.6

1.2

128.13

601.45

pmol/l

—

Fracture at wrist and hand level

320

3028

1.05

0.41

1.4

118.41

143.81

pmol/l

0.45

312

2944

Postpartum haemorrhage due to retained placenta

212

1990

1.07

0.41

1.4

51.11

81.14

pmol/l

2.85

205

1939

HSIL lesion of the vulva

241

1.21

0.40

1.4

234.76

286.46

pmol/l

0.12

236

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

137

1482

0.92

0.40

1.3

1.5

111.37

163.11

pmol/l

1.48

137

1447

Injury of muscle and tendon at hip and thigh level

815

0.89

0.40

1.5

61.64

167.39

pmol/l

3.76

800

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

274

2592

1.06

0.40

1.3

1.5

94.71

143.52

pmol/l

2.56

269

2517

Oesophagitis

347

0.83

0.40

1.2

1.6

157.14

228.67

pmol/l

0.53

342

Hyperkinetic disorders, excluding more controls

150

1297

1.08

0.40

1.4

51.76

53.68

pmol/l

0.08

142

1252

Prominent ears

103

0.67

0.40

1.3

39.57

85.38

pmol/l

—

L04AC Interleukin inhibitors

597

1.13

0.40

1.3

1.4

71.85

161.52

pmol/l

1.95

586

Other specified and unspecified disorders of choroid

1.44

0.39

1.2

1.3

40.80

79.61

pmol/l

—

Insulin, fast-acting

273

2880

0.95

0.39

1.4

1.5

144.13

156.76

pmol/l

0.22

264

2802

Other nonscarring hair loss

169

1.25

0.39

1.4

58.11

192.37

pmol/l

1.15

164

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.39

0.0

1.3

—

242.66

—

Sequelae of injuries of head

324

0.83

0.39

1.4

1.5

64.17

206.44

pmol/l

1.87

319

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

863

7704

0.97

0.39

1.4

99.19

117.69

pmol/l

0.59

843

7524

Immunodeficiencies

438

1.15

0.38

1.6

1.5

125.80

187.30

pmol/l

0.59

429

Anomalies of dental arch relationship, including avohilmo

210

2018

0.94

0.38

1.4

1.5

82.52

130.50

pmol/l

1.68

202

1959

Primary amenorrhea

1.36

0.38

1.4

45.42

89.00

pmol/l

0.49

Implicit Sepsis, including avohilmo

956

6633

1.03

0.38

1.5

1.4

171.91

138.23

pmol/l

1.29

926

6474

Post-traumatic wound infection, not elsewhere classified

181

0.77

0.38

1.3

1.4

168.50

174.63

pmol/l

0.02

176

Other arthritis (FG)

341

3574

0.95

0.38

1.4

178.65

140.61

pmol/l

0.42

331

3488

Short Achilles tendon (acquired)

301

0.83

0.38

1.2

1.6

61.30

137.34

pmol/l

1.55

296

Mental and behavioural disorders due to sedatives or hypnotics

526

0.87

0.38

1.5

152.48

175.36

pmol/l

0.10

518

Heart failure and bmi 25plus

228

1612

0.94

0.38

1.5

310.69

188.67

pmol/l

0.91

222

1568

Other disorders of patella

231

2181

1.06

0.38

1.4

1.5

122.34

127.12

pmol/l

0.06

225

2126

Hypertrophy of breast in women and men

320

3049

1.05

0.38

1.4

1.5

104.94

131.26

pmol/l

0.72

309

2977

Injury of nerves at wrist and hand level

243

1.20

0.37

1.2

1.3

99.79

157.34

pmol/l

0.39

236

Varus deformity, not elsewhere classified

111

0.72

0.37

1.1

1.4

71.50

383.04

pmol/l

—

111

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

115

0.69

0.37

1.4

69.88

107.41

pmol/l

—

110

Pediculosis, acariasis and other infestations, including avohilmo

185

1735

1.07

0.37

1.4

1.5

70.27

121.29

pmol/l

2.34

180

1690

Diabetes mellitus

1390

7837

1.02

0.37

1.4

169.78

117.61

pmol/l

1.65

1351

7650

Care involving use of rehabilitation procedures

679

6303

0.97

0.37

1.5

1.4

133.23

102.62

pmol/l

0.77

657

6170

Conjunctivitis (acute, non atopic)

341

3242

1.05

0.37

1.5

1.4

104.64

138.91

pmol/l

1.10

332

3150

Herpesviral keratitis and keratoconjunctivitis

343

0.84

0.36

1.1

1.5

108.49

215.03

pmol/l

1.16

337

Other enthesopathies

408

3912

1.04

0.36

1.5

1.4

96.72

140.96

pmol/l

4.03

398

3825

Any mental disorder

1416

6927

1.02

0.36

1.4

134.12

133.59

pmol/l

0.01

1379

6759

Procedures for purposes other than remedying health state

300

1.17

0.36

1.5

1.4

92.66

216.69

pmol/l

1.22

294

Allergic contact dermatitis

195

1835

1.06

0.36

1.3

1.5

81.87

147.03

pmol/l

2.96

190

1793

Fracture of femur

194

1858

0.94

0.36

1.4

1.5

226.80

251.93

pmol/l

0.23

185

1808

Systemic lupus erythematosus, unspecified

347

1.16

0.36

1.4

1.5

137.25

212.60

pmol/l

0.52

338

Nonsuppurative otitis media

240

1970

1.06

0.36

1.6

1.5

79.63

117.10

pmol/l

1.70

229

1908

Complications of genitourinary prosthetic devices, implants and grafts

226

1.20

0.36

1.6

1.4

87.81

203.44

pmol/l

1.16

221

Use of interferon beta-1a

288

0.83

0.36

1.5

1.4

69.20

114.01

pmol/l

0.55

281

Molar incisor enamel hypoplasia

265

0.83

0.36

1.4

173.22

113.37

pmol/l

0.27

251

Other bursopathies

129

1197

1.08

0.35

1.4

116.22

167.06

pmol/l

1.15

129

1173

Other and unspecified acne

135

1.27

0.35

1.7

1.4

58.82

172.92

pmol/l

0.75

130

Periodontitis

1207

7872

0.98

0.35

1.4

147.40

136.07

pmol/l

0.28

1174

7691

Benign neoplasm: Conjunctiva

266

0.82

0.35

1.4

65.36

263.93

pmol/l

2.26

261

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

125

1346

0.93

0.35

1.3

1.5

107.51

165.68

pmol/l

1.70

125

1315

Cerebral cysts

489

1.13

0.35

1.4

1.5

68.62

161.29

pmol/l

1.82

476

Disorders of lacrimal system and orbit in diseases classified elsewhere

298

0.83

0.35

1.1

1.4

73.20

236.47

pmol/l

1.93

291

Autoimmune hepatitis, wide definition

423

1.14

0.35

1.4

1.5

99.58

186.04

pmol/l

1.71

414

Hypertrophy of breast

319

3048

1.05

0.35

1.4

1.5

105.05

131.28

pmol/l

0.72

308

2976

Other endophthalmitis

1.37

0.34

1.3

67.38

405.12

pmol/l

—

Hypoplasia of dental enamel , including avohilmo

255

0.83

0.34

1.4

179.86

112.46

pmol/l

0.30

241

Fall on same level

1460

7947

0.98

0.34

1.4

110.95

128.44

pmol/l

1.16

1418

7752

Graves ophthalmopathy

297

0.84

0.34

1.1

1.4

73.20

214.05

pmol/l

1.67

291

Internal derangement of knee

422

4018

1.04

0.34

1.4

1.5

108.68

135.61

pmol/l

0.95

404

3924

Type 2 diabetes, definitions combined, including avohilmo

1293

7305

1.02

0.34

1.4

170.71

122.41

pmol/l

1.31

1256

7136

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

246

2036

1.05

0.34

1.4

1.5

56.36

65.21

pmol/l

0.42

235

1963

Other and unspecified disorders of vitreous body

520

4910

1.04

0.34

1.5

1.4

129.96

176.02

pmol/l

1.76

512

4795

Chromosomal abnormalities, not elsewhere classified

163

1.23

0.33

1.2

1.3

63.55

82.25

pmol/l

0.33

157

Maxillary retrognathism

144

0.76

0.33

1.1

1.3

64.64

162.95

pmol/l

0.66

138

Idiopathic thrombocytopenic purpura

210

0.81

0.33

1.2

1.4

115.41

262.22

pmol/l

1.02

205

Other peripheral vertigo

893

1.09

0.33

1.6

1.5

111.03

199.58

pmol/l

1.94

874

Maternal care related to the fetus and amniotic cavity and possible delivery problems

830

4999

0.97

0.33

1.4

75.45

113.43

pmol/l

3.46

811

4883

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

177

0.79

0.33

1.6

1.4

135.06

93.11

pmol/l

0.47

172

Bruxism

242

0.82

0.33

1.5

1.4

115.35

156.53

pmol/l

0.20

237

Syncope and collapse

449

3610

1.04

0.33

1.4

165.43

151.48

pmol/l

0.23

434

3512

Pre-eclampsia or poor fetal growth

550

5656

0.97

0.33

1.4

80.62

104.15

pmol/l

2.34

544

5511

Spirochaetal infections, other/unspecified, including avohilmo

408

3926

1.04

0.33

1.4

107.14

154.50

pmol/l

1.73

399

3827

Lesion of sciatic nerve

253

0.83

0.33

1.7

1.5

119.05

284.10

pmol/l

2.01

248

Excessive earwax

666

5853

1.03

0.33

1.4

127.03

161.44

pmol/l

0.96

648

5712

Covid-19 suspected case

267

2546

1.05

0.32

1.4

1.5

119.74

116.00

pmol/l

0.06

262

2482

ILD, hospital admission 2, with pulmonary infections

592

0.89

0.32

1.6

1.5

288.09

252.14

pmol/l

0.13

575

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

332

1.15

0.32

1.3

1.4

60.26

167.62

pmol/l

1.37

325

Injuries to the elbow and forearm

942

7872

1.03

0.32

1.5

1.4

137.48

139.89

pmol/l

0.06

910

7670

Abnormal findings on antenatal screening of mother

146

1370

1.07

0.31

1.3

1.5

45.58

60.17

pmol/l

2.39

140

1328

Gonarthrosis

710

4126

0.97

0.31

1.4

165.76

142.31

pmol/l

0.40

689

4035

Open wound of hip and thigh

202

1.19

0.31

1.5

1.4

61.77

140.70

pmol/l

0.78

194

Personality disorders

308

3213

0.96

0.31

1.5

105.56

109.59

pmol/l

0.05

301

3126

Injury of other and unspecified intrathoracic organs

286

1.16

0.31

1.5

189.73

232.79

pmol/l

0.17

280

Pneumonia due to other infectious organisms, not elsewhere classified

240

0.83

0.31

1.6

1.4

231.65

188.01

pmol/l

0.11

235

Lyme disease, including avohilmo

405

3906

1.04

0.30

1.4

1.5

107.50

154.99

pmol/l

1.72

396

3808

Lyme disease

405

3906

1.04

0.30

1.4

1.5

107.50

154.99

pmol/l

1.72

396

3808

Injuries to the ankle and foot

952

7937

1.02

0.30

1.5

1.4

107.69

123.93

pmol/l

0.72

922

7742

LSIL lesion of the cervix uteri

206

1958

1.05

0.30

1.4

1.5

67.07

106.52

pmol/l

2.10

201

1914

Other spirochaetal diseases, including avohilmo

413

3986

1.04

0.30

1.4

1.5

106.41

153.99

pmol/l

1.78

404

3886

Chronic lower respiratory diseases

1571

8116

1.02

0.30

1.5

1.4

136.39

126.17

pmol/l

0.26

1537

7899

Rheumatoid arthritis

379

3481

0.96

0.30

1.5

197.74

154.27

pmol/l

0.51

370

3397

Mental and behavioural disorders due to alcohol, excluding acute intoxication

268

2776

0.96

0.30

1.4

1.5

156.19

131.29

pmol/l

0.29

261

2703

Maternal care for known or suspected malpresentation of fetus

377

2589

1.04

0.29

1.4

54.04

63.64

pmol/l

1.13

368

2527

Alcohol use disorder, ICD-based

247

2586

0.95

0.29

1.4

1.5

146.31

130.72

pmol/l

0.16

241

2519

Congenital deformities of feet, including avohilmo

363

1.13

0.29

1.2

1.4

65.63

131.93

pmol/l

1.18

355

Exclusions for E4_PCOS_BROAD

173

1635

1.06

0.29

1.4

1.5

90.95

146.60

pmol/l

2.03

167

1593

Viral agents as the cause of diseases classified to other chapters

195

0.82

0.29

1.3

1.4

60.81

176.18

pmol/l

1.12

189

Diabetes, insulin treatment (Kela reimbursement)

1220

7403

0.98

0.28

1.4

194.11

131.42

pmol/l

1.89

1186

7237

Allergic rhinitis

389

3976

0.96

0.28

1.4

1.5

90.32

108.70

pmol/l

0.64

378

3873

Other specified and unspecified retinal disorders

270

1.15

0.28

1.5

204.21

267.90

pmol/l

0.24

264

Childhood allergy (age < 16)

124

1089

0.94

0.28

1.3

1.4

45.82

46.55

pmol/l

0.08

118

1031

Type 2 diabetes, wide definition

913

5624

1.02

0.27

1.5

1.4

241.49

139.58

pmol/l

2.83

885

5500

Chronic periodontitis, including avohilmo

1209

7860

0.98

0.27

1.4

139.24

137.45

pmol/l

0.04

1176

7681

Bleeding

842

6039

0.98

0.27

1.5

1.4

186.95

152.43

pmol/l

0.70

814

5899

Chronic conjunctivitis

290

0.86

0.27

1.4

97.20

239.49

pmol/l

1.27

284

LSIL lesion of the vagina

224

1.17

0.27

1.2

1.4

110.38

171.99

pmol/l

0.45

219

Arthropod-borne viral fevers and viral haemorrhagic fevers

633

1.09

0.27

1.4

1.5

103.95

199.52

pmol/l

1.67

621

Contact with nonpowered hand tool

172

0.81

0.27

1.4

56.86

163.47

pmol/l

0.96

167

Hyperkinetic disorders (excl. ADHD)

102

1.26

0.27

1.4

1.3

46.54

84.64

pmol/l

0.51

Other and unspecified tonsillitis

327

2820

0.96

0.27

1.4

1.5

61.27

87.30

pmol/l

1.93

311

2748

Diseases of the eye and adnexa

1032

5060

1.02

0.27

1.5

1.4

108.58

120.77

pmol/l

0.35

1015

4929

Mental disorders, not otherwise specified

916

0.93

0.27

1.4

1.5

70.81

140.42

pmol/l

1.86

895

Villonodular synovitis (pigmented)

1.22

0.27

1.3

54.63

283.73

pmol/l

—

Falls/tendency to fall

1393

7102

0.98

0.27

1.4

128.06

126.07

pmol/l

0.05

1351

6938

Corneal scars and opacities

193

0.83

0.26

1.0

1.5

146.27

184.38

pmol/l

0.20

188

Atrial septal defect

279

1.14

0.26

1.4

82.36

138.86

pmol/l

0.70

272

SLE, strict definition

395

1.12

0.26

1.4

1.5

165.50

206.34

pmol/l

0.25

386

SLE, ICD10

395

1.12

0.26

1.4

1.5

165.50

206.34

pmol/l

0.25

386

Benign neoplasm: Short bones of upper limb

149

0.80

0.26

1.3

73.92

138.51

pmol/l

0.69

144

Disorders of orbit

453

1.11

0.26

1.4

1.5

90.39

251.94

pmol/l

2.62

443

Other spirochaetal diseases

406

3933

1.03

0.26

1.4

1.5

107.45

154.64

pmol/l

1.71

397

3835

Benign neoplasm: Other and unspecified parts of mouth

263

1.14

0.25

1.4

1.5

61.17

239.84

pmol/l

2.03

256

Thyrotropin deficiency

123

1.23

0.25

1.3

66.08

191.97

pmol/l

0.75

118

Graves ophthalmopathy, strict

256

0.86

0.25

1.1

1.4

76.91

234.87

pmol/l

1.59

250

Other disorders of amniotic fluid and membranes

237

2384

0.96

0.25

1.5

1.4

68.42

78.16

pmol/l

0.29

230

2325

1165

6934

0.98

0.25

1.5

1.4

153.45

129.39

pmol/l

0.66

1137

6770

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1165

6934

0.98

0.25

1.5

1.4

153.45

129.39

pmol/l

0.66

1137

6770

Thyrotoxicosis

360

3482

1.03

0.25

1.4

1.5

184.99

149.62

pmol/l

0.28

352

3390

Diabetes, varying definitions

1375

7831

1.02

0.25

1.4

170.94

117.75

pmol/l

1.67

1336

7645

Pollen allergy

214

2203

0.96

0.25

1.4

67.42

105.68

pmol/l

1.90

208

2144

Effects of other external causes

207

1.16

0.25

1.4

60.42

81.98

pmol/l

0.43

202

Unspecified fall

541

5168

1.03

0.25

1.4

1.5

161.99

153.19

pmol/l

0.13

526

5028

Arteriovenous malformation of cerebral vessels

1.26

0.25

1.4

123.75

229.13

pmol/l

0.37

Hyperlipidaemia, other/unspecified

321

2785

1.04

0.24

1.4

217.99

182.78

pmol/l

0.24

308

2729

Other disorders of eyelid

501

4597

1.03

0.24

1.4

110.36

191.58

pmol/l

6.61

490

4482

Foreign body entering into or through eye or natural orifice

434

0.90

0.24

1.2

1.5

94.95

191.14

pmol/l

1.17

423

Spondyloarthritis

165

1571

1.05

0.24

1.4

1.5

127.62

152.34

pmol/l

0.41

160

1530

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

735

1.08

0.24

1.4

1.6

82.74

228.34

pmol/l

4.87

718

Conotruncal defects

0.71

0.24

1.0

1.3

52.33

187.71

pmol/l

—

Erythema multiforme

208

1.16

0.24

1.3

1.4

257.79

214.30

pmol/l

0.12

202

Ehlers-Danlos syndrome

152

1.19

0.24

1.4

50.06

90.25

pmol/l

0.89

145

Disorders of adult personality and behaviour

327

3381

0.97

0.24

1.5

101.64

104.56

pmol/l

0.04

320

3285

Cardiac arrest

270

0.88

0.24

1.7

1.5

183.54

239.45

pmol/l

0.31

261

Wet age-related macular degeneration

128

1167

1.06

0.24

1.4

1.5

163.21

298.05

pmol/l

3.02

121

1123

D07AA Corticosteroids, weak (group I)

165

1570

1.05

0.23

1.4

1.5

71.01

128.85

pmol/l

3.15

159

1532

Other disorders involving the immune mechanism, not elsewhere classified

190

0.84

0.23

1.6

1.4

123.43

123.15

pmol/l

0.00

185

Ehlers-Danlos syndrome, including avohilmo

190

1.17

0.23

1.4

51.05

81.10

pmol/l

0.80

182

Autoimmune hyperthyroidism

843

1.07

0.23

1.4

1.5

184.65

146.48

pmol/l

0.14

826

Impacted maxillary molar

661

0.92

0.23

1.2

1.5

48.24

73.43

pmol/l

0.78

637

Injuries to the thorax

387

3752

1.03

0.23

1.5

1.4

131.19

170.09

pmol/l

1.44

374

3641

Haemangioma and lymphangioma, any site

911

1.07

0.23

1.3

1.5

81.05

178.01

pmol/l

2.43

892

Insulin, intermediate and long-acting

433

4295

0.97

0.23

1.4

173.54

160.71

pmol/l

0.24

420

4184

Cerebrovascular diseases (FINNGEN)

354

2402

1.03

0.23

1.5

1.4

136.48

113.81

pmol/l

0.49

346

2349

Benign neoplasm: Short bones of lower limb

1.24

0.23

1.7

1.4

57.58

229.92

pmol/l

0.84

Mandibular retrognathia AND surgery (BSSO)

285

0.87

0.23

1.6

1.4

75.63

139.77

pmol/l

0.68

278

Fall on and from ladder

264

0.87

0.23

1.4

133.35

274.98

pmol/l

0.89

259

Open wound of lower leg

134

1272

1.05

0.23

1.7

1.5

111.47

162.07

pmol/l

0.98

127

1232

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

323

1.12

0.23

1.3

1.5

199.52

231.78

pmol/l

0.11

315

Anisometropia and aniseikonia

274

0.87

0.22

1.5

1.4

118.25

216.37

pmol/l

0.59

266

Patent foramen ovale

157

0.83

0.22

1.3

1.4

41.48

162.71

pmol/l

1.03

151

Fracture of forearm

730

6693

0.98

0.22

1.5

1.4

145.06

149.88

pmol/l

0.10

704

6522

Rotator cuff syndrome

690

4853

0.98

0.22

1.4

136.10

147.78

pmol/l

0.34

668

4747

Benign neoplasm of mouth and pharynx

903

1.06

0.22

1.5

95.06

196.76

pmol/l

2.65

883

Leisure time condition

169

1616

1.05

0.22

1.4

1.5

127.03

158.85

pmol/l

0.62

164

1570

Autoimmune diseases excluding thyroid diseases

1266

6748

1.02

0.22

1.4

155.80

120.71

pmol/l

1.14

1232

6574

Pseudosarcomatous fibromatosis

0.00

0.22

0.0

1.2

—

70.64

—

Vibratory urticaria

0.00

0.22

0.0

1.4

—

66.86

—

Other congenital malformations of skin

372

1.10

0.22

1.3

1.5

80.33

180.85

pmol/l

1.37

364

Other congenital malformations of ear

124

0.80

0.22

1.5

1.3

38.90

84.48

pmol/l

—

117

Synovial cyst of popliteal space [Baker]

700

1.07

0.22

1.4

1.5

107.20

172.25

pmol/l

1.67

686

Use of amantadine

163

1.17

0.21

1.7

1.5

71.37

210.24

pmol/l

1.13

158

Profound mental retardation

0.00

0.21

0.0

1.5

—

51.05

—

Fusion of the labia, including avohilmo

0.00

0.21

0.0

1.0

—

52.50

—

Multiple superficial injuries of ankle and foot

0.00

0.21

0.0

1.3

—

50.50

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.21

0.0

1.2

—

53.82

—

Nonadministration of surgical and medical care

0.00

0.21

0.0

1.3

—

57.82

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.5

—

49.87

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.4

—

49.50

—

Other retinal disorders in diseases classified elsewhere

0.00

0.21

0.0

1.5

—

47.34

—

Short stature starting before birth

0.00

0.21

0.0

1.7

—

41.18

—

Ebstein's anomaly

0.00

0.21

0.0

1.3

—

51.58

—

Postinflammatory hyperpigmentation

0.00

0.21

0.0

1.2

—

69.75

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.21

0.0

1.3

—

65.05

—

Erythrasma

0.00

0.21

0.0

1.3

—

65.88

—

Burns and corrosions

977

0.94

0.21

1.5

157.43

155.67

pmol/l

0.01

954

Concussion

623

4935

0.98

0.21

1.4

111.74

125.01

pmol/l

0.47

602

4822

Paralytic strabismus

488

1.09

0.21

1.3

1.5

80.58

219.80

pmol/l

2.97

481

Intentional self-harm by sharp object

209

0.86

0.21

1.6

1.4

56.61

83.93

pmol/l

0.74

199

Autoimmune diseases excluding thyroid diseases, strict definition

1220

6528

1.02

0.21

1.4

158.71

121.22

pmol/l

1.19

1187

6359

Hypotony of eye

0.00

0.21

0.0

1.1

—

848.77

—

Chronic nephritic syndrome

211

1.14

0.20

1.5

1.4

311.29

188.67

pmol/l

0.41

206

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.20

0.0

1.2

—

810.46

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

709

1.07

0.20

1.5

1.4

68.63

93.35

pmol/l

0.61

689

Tracheo-bronchomalasia

1.26

0.20

1.2

1.5

331.83

197.02

pmol/l

—

Vitamin B12 deficiency anaemia

741

1.07

0.20

1.4

238.04

214.89

pmol/l

0.07

717

Dengue fever [classical dengue], including avohilmo

0.00

0.20

0.0

1.4

—

50.33

—

Relapsing fevers

0.00

0.20

0.0

1.1

—

68.93

—

Melanoma in situ of scalp and neck

0.00

0.20

0.0

1.5

—

90.93

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

261

0.88

0.20

1.3

1.4

264.35

275.77

pmol/l

0.02

256

Congenital malformations of larynx

0.00

0.20

0.0

1.3

—

69.26

—

Contact with and exposure to communicable diseases

403

3907

1.03

0.20

1.5

1.4

76.22

90.68

pmol/l

0.43

388

3799

Complications of labour and delivery

1238

6772

1.02

0.20

1.4

99.00

131.74

pmol/l

2.52

1209

6601

Retinal detachment with retinal break

841

0.94

0.20

1.4

1.5

184.15

208.10

pmol/l

0.13

822

Primary open-angle glaucoma

276

2571

1.03

0.20

1.4

1.5

199.25

225.28

pmol/l

0.36

265

2503

Contusion of toe(s) without damage to nail

288

1.11

0.20

1.4

136.69

114.86

pmol/l

0.09

282

Acute laryngitis and tracheitis

116

1086

1.05

0.19

1.6

1.4

61.63

120.26

pmol/l

2.29

111

1057

Panniculitis affecting regions of neck and back

298

1.11

0.19

1.6

1.5

161.45

192.62

pmol/l

0.15

293

Epilepsy

269

2766

0.97

0.19

1.4

137.48

167.06

pmol/l

0.59

263

2693

Other neurotic disorders

364

0.91

0.19

1.4

1.5

115.00

234.90

pmol/l

1.22

356

Contact with machinery

241

1.12

0.19

1.4

72.33

224.07

pmol/l

1.40

235

Early complications of trauma

270

0.89

0.19

1.3

1.4

158.04

200.04

pmol/l

0.22

265

!Aliquae complicationes praecoces traumatis

270

0.89

0.19

1.3

1.4

158.04

200.04

pmol/l

0.22

265

Other disorders of eye and adnexa

166

1595

1.04

0.19

1.4

1.5

92.53

149.91

pmol/l

2.00

159

1552

Manic episode

238

0.88

0.18

1.2

1.4

181.00

218.30

pmol/l

0.14

233

Iridocyclitis

231

2236

1.03

0.18

1.4

266.01

151.21

pmol/l

1.10

221

2178

Dermatophytosis, including avohilmo

747

7189

1.02

0.18

1.4

122.06

134.66

pmol/l

0.19

727

7016

Other and unspecified injuries of head

590

1.07

0.18

1.4

1.5

104.88

222.97

pmol/l

2.02

574

Meniscus derangement

586

3963

0.98

0.17

1.4

165.38

145.99

pmol/l

0.29

567

3875

1.13

0.17

2.3

1.3

52.29

41.22

pmol/l

—

Fall on same level involving ice and snow

715

7025

1.02

0.17

1.4

151.23

143.02

pmol/l

0.13

686

6859

Sacroiliitis, not elsewhere classified

504

1.07

0.17

1.6

1.5

73.54

143.37

pmol/l

1.21

494

Malignant neoplasm of oral cavity, including Hilmo

167

1.14

0.16

1.5

1.4

81.74

81.99

pmol/l

0.00

162

Persistent mood disorders

208

2147

0.97

0.16

1.4

129.47

148.01

pmol/l

0.24

201

2091

Asthma-related pneumonia

347

3542

0.98

0.16

1.6

1.4

221.92

170.15

pmol/l

0.63

336

3448

Polyarthritis, unspecified

311

1.10

0.16

1.6

1.5

197.49

223.01

pmol/l

0.11

306

Other protozoal intestinal diseases

141

0.85

0.16

1.2

1.4

43.50

206.29

pmol/l

1.14

134

Artificial joint operation, meniscal resection

975

6321

0.99

0.16

1.4

220.99

145.64

pmol/l

1.40

949

6173

Spondylopathies (FG)

141

1356

1.04

0.16

1.5

1.4

94.31

131.74

pmol/l

1.10

136

1323

Vertical strabismus

292

1.10

0.16

1.4

1.5

61.00

217.49

pmol/l

2.05

287

Fracture of shoulder and upper arm

359

3669

0.98

0.16

1.5

150.24

180.67

pmol/l

0.56

349

3569

Postpartum hemorraghe, all women as controls

482

4609

1.02

0.16

1.4

53.88

89.44

pmol/l

6.70

467

4500

Primary open-angle glaucoma, strict

227

2198

1.03

0.16

1.4

1.5

224.30

234.34

pmol/l

0.10

217

2138

Cauda equina syndrome

130

0.84

0.16

1.3

1.4

62.00

190.95

pmol/l

0.86

125

Systemic atrophies primarily affecting the central nervous system

256

0.90

0.16

1.4

1.5

117.04

295.48

pmol/l

1.22

251

Other and unspecified corneal deformities and disorders

287

0.90

0.16

1.3

1.4

75.05

226.13

pmol/l

2.08

281

Deviated nasal septum

224

2172

1.03

0.16

1.4

114.86

147.95

pmol/l

0.56

214

2126

Paraplegia, diplegia of upper limbs

149

1.14

0.15

1.5

1.4

108.53

214.91

pmol/l

0.64

144

Other congenital malformations of tongue, mouth and pharynx

0.76

0.15

1.5

268.27

53.23

pmol/l

—

Injury of nerves at forearm level

1.21

0.15

1.4

1.3

80.30

77.83

pmol/l

—

Gestational diabetes (for exclusion)

716

5001

0.98

0.15

1.4

64.06

80.49

pmol/l

1.72

695

4883

Plantar fascial fibromatosis

133

1280

1.04

0.15

1.4

118.80

143.22

pmol/l

0.33

128

1257

Unspecified event, undetermined intent

197

1.12

0.15

1.4

263.95

147.55

pmol/l

0.28

192

Other demyelinating diseases of the central nervous system

431

0.93

0.15

1.2

1.5

58.47

116.14

pmol/l

1.24

424

L04AA Selective immunosuppressants

234

2406

0.97

0.15

1.6

1.4

137.43

146.54

pmol/l

0.18

225

2343

Polyarthropathies

789

5141

0.98

0.15

1.4

176.89

124.67

pmol/l

1.24

773

5017

Pneumococcal septicemia

203

0.89

0.15

1.3

1.4

430.06

291.12

pmol/l

0.18

198

Primary coxarthrosis, bilateral

256

2493

1.03

0.15

1.4

1.5

152.69

233.41

pmol/l

2.43

247

2430

Gender identity disorders

102

1.18

0.15

1.1

1.4

47.33

80.46

pmol/l

0.42

Other hammer toe(s) (acquired)

216

2021

0.97

0.15

1.4

1.5

130.60

194.14

pmol/l

2.25

209

1970

Other/unspecified enthesopathies, not elsewhere classified

781

1.05

0.15

1.4

1.5

136.79

150.59

pmol/l

0.18

766

Abnormalities of forces of labour

170

1755

0.97

0.15

1.3

1.4

106.79

95.41

pmol/l

0.13

165

1718

Other/unspecified synovitis and tenosynovitis

132

1272

1.04

0.14

1.5

1.4

115.18

149.81

pmol/l

0.66

126

1245

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

376

3792

0.98

0.14

1.4

81.09

94.54

pmol/l

0.39

365

3690

Other and unspecified nerve root and plexus disorders, also in other diseases

208

2139

0.97

0.14

1.4

79.77

152.67

pmol/l

3.59

200

2083

Injury of nerves at shoulder and upper arm level

0.83

0.14

2.5

1.5

67.60

202.11

pmol/l

—

Trigger finger

174

1793

0.97

0.14

1.4

83.62

143.45

pmol/l

4.70

168

1754

Neuralgia and neuritis, unspecified

521

0.94

0.14

1.6

1.5

71.53

146.30

pmol/l

2.15

513

Ankle and foot

100

0.80

0.13

1.5

1.3

50.75

240.34

pmol/l

—

Pregnancy with abortive outcome

1314

6771

1.01

0.13

1.5

1.4

160.14

134.74

pmol/l

0.60

1273

6595

Asthma-related pneumonia or sepsis

349

3549

0.98

0.13

1.6

1.4

220.88

170.16

pmol/l

0.62

338

3455

Asthma, hospital admissions 3, pneumonia

349

3549

0.98

0.13

1.6

1.4

220.88

170.16

pmol/l

0.62

338

3455

Fall on and from stairs and steps

278

2717

1.02

0.13

1.4

144.31

165.10

pmol/l

0.42

269

2639

Congenital malformations of the musculoskeletal system, not elsewhere classified

199

1.11

0.13

1.4

48.45

138.66

pmol/l

0.95

192

Papulosquamous disorders

419

4267

0.98

0.13

1.4

119.86

159.55

pmol/l

1.30

411

4159

Abrasion of teeth

490

4819

1.02

0.13

1.5

1.4

79.86

143.70

pmol/l

8.24

477

4711

Conduction disorders

228

1873

0.97

0.13

1.5

1.4

220.18

197.17

pmol/l

0.21

223

1828

Hypertensive heart and/or renal disease

175

1240

1.03

0.13

1.4

1.5

410.58

212.55

pmol/l

1.28

169

1211

Other extrapyramidal and movement disorders in other diseases

250

2560

0.98

0.13

1.3

1.5

159.34

182.82

pmol/l

0.12

242

2487

Hereditary deficiency of other clotting factors

109

0.82

0.13

1.1

1.3

54.56

101.88

pmol/l

—

104

Hallux valgus (acquired)

507

3565

1.02

0.13

1.4

128.11

154.15

pmol/l

1.09

491

3483

Benign neoplasm: Skin of scalp and neck

209

1.10

0.13

1.4

76.04

234.54

pmol/l

1.23

204

Poisoning by narcotics and psychodysleptics [hallucinogens]

109

0.82

0.13

2.6

1.4

87.36

97.68

pmol/l

—

104

Senile cataract

588

3628

0.98

0.13

1.4

1.5

158.22

172.02

pmol/l

0.24

571

3545

Actinic keratosis

315

2805

1.02

0.13

1.5

211.15

231.08

pmol/l

0.27

305

2734

Periapical abscess

489

4811

1.02

0.13

1.4

117.44

132.22

pmol/l

0.41

471

4704

Embedded and impacted teeth

298

2470

0.98

0.13

1.5

53.56

85.89

pmol/l

2.89

284

2388

Other inflammation of eyelid

160

1553

1.03

0.13

1.4

74.05

182.71

pmol/l

8.45

155

1520

Acute and transient psychotic disorders

102

1059

0.96

0.12

1.3

1.5

98.39

161.49

pmol/l

1.61

1038

Varicella [chickenpox], including avohilmo

277

1.08

0.12

1.3

1.4

63.57

143.86

pmol/l

1.06

269

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1171

7014

0.99

0.12

1.4

183.25

125.63

pmol/l

1.63

1138

6856

Superficial injury of thorax

116

1201

0.97

0.12

1.4

1.5

100.94

166.05

pmol/l

1.34

111

1172

Dipeptidyl peptidase 4 (DPP-4) inhibitors

497

3956

0.98

0.12

1.4

242.01

166.14

pmol/l

0.93

482

3860

Pure hypercholesterolaemia

811

5085

1.01

0.12

1.5

1.4

222.38

143.32

pmol/l

2.24

783

4980

Disturbance of activity and attention

146

1383

1.03

0.12

1.4

52.03

56.98

pmol/l

0.22

138

1331

Nonpyogenic thrombosis of intracranial venous system

1.16

0.11

1.8

1.4

146.18

61.30

pmol/l

0.45

Valvular heart disease excluding rheumatic fever

430

3019

1.02

0.11

1.4

147.30

175.31

pmol/l

0.70

417

2946

Other sexually transmitted chlamydial diseases

670

1.05

0.11

1.4

45.34

57.35

pmol/l

1.17

650

Injuries to the hip and thigh

443

4032

0.98

0.11

1.4

1.5

149.63

178.87

pmol/l

0.70

420

3930

Haemangioma, any site

867

1.04

0.11

1.4

1.5

83.04

177.67

pmol/l

2.18

850

Coxarthrosis [arthrosis of hip](FG)

562

3918

0.99

0.11

1.4

160.10

157.25

pmol/l

0.04

551

3834

Pediculosis, acariasis and other infestations

406

1.06

0.11

1.5

1.4

54.33

164.14

pmol/l

1.94

396

Open wound of forearm

661

1.04

0.11

1.5

103.72

168.23

pmol/l

1.09

640

Duodenal ulcer

504

1.05

0.11

1.6

1.5

334.95

239.33

pmol/l

0.40

492

Accidents

1105

5482

1.01

0.11

1.4

123.00

135.81

pmol/l

0.34

1077

5363

Non-small cell lung cancer, adenocarcinoma, helper endpoint

377

1.06

0.11

1.4

1.6

167.28

290.12

pmol/l

0.94

370

Tuberculosis

301

0.93

0.10

1.3

1.5

126.75

308.66

pmol/l

1.94

295

Cleft lip, lip and palate or palate

146

0.89

0.10

1.6

1.4

82.92

80.33

pmol/l

0.03

140

Congenital deformities of feet

241

1.08

0.10

1.2

1.4

75.08

158.43

pmol/l

0.91

235

Degenerative macular diseases

942

0.97

0.10

1.3

1.5

287.66

220.00

pmol/l

0.24

912

Spondylopathies

913

5342

1.01

0.10

1.4

151.05

145.68

pmol/l

0.08

887

5218

Other salmonella infections, including avohilmo

372

0.94

0.10

1.5

170.94

220.69

pmol/l

0.28

364

Tooth eruption problems

149

1476

0.97

0.10

1.5

1.4

50.46

89.83

pmol/l

2.25

143

1423

Hyperkinetic disorders

150

1425

1.03

0.10

1.4

51.76

57.79

pmol/l

0.29

142

1374

Sensorineural hearing loss

809

5335

1.01

0.10

1.5

1.4

152.11

165.14

pmol/l

0.28

787

5208

Other maltreatment syndromes

193

1.09

0.10

1.3

1.4

67.62

142.49

pmol/l

0.69

187

1.11

0.10

1.0

1.3

968.00

334.50

pmol/l

—

Fracture of rib(s), sternum and thoracic spine

216

2117

1.02

0.09

1.6

1.4

142.04

197.53

pmol/l

1.46

211

2053

Fracture of foot, except ankle

279

2742

1.02

0.09

1.4

1.5

106.49

132.57

pmol/l

0.92

272

2669

Hypermetropia

645

0.96

0.09

1.3

1.5

98.98

189.95

pmol/l

1.69

630

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

136

1326

1.03

0.09

1.5

1.4

76.02

94.82

pmol/l

0.51

131

1295

Viral warts, including avohilmo

235

2307

1.02

0.09

1.5

1.4

77.74

126.64

pmol/l

3.51

227

2246

Acute and subacute iridocyclitis

187

1832

1.02

0.09

1.4

300.06

151.45

pmol/l

1.22

181

1787

Vasomotor and allergic rhinitis

490

4843

0.99

0.09

1.5

1.4

114.68

120.99

pmol/l

0.12

475

4721

Atopic dermatitis, strict definition with reimbursement

403

3921

0.99

0.09

1.4

67.92

106.85

pmol/l

3.68

392

3816

Dependent personality disorder

206

0.92

0.08

1.7

1.4

235.05

246.55

pmol/l

0.03

201

Congenital malformations of the nervous system

206

0.92

0.08

1.9

1.3

47.11

88.94

pmol/l

1.42

200

Impacted teeth

214

1870

0.98

0.08

1.4

52.94

80.00

pmol/l

1.76

202

1804

Symptoms and signs involving cognition, perception, emotional state and behaviour

1216

8177

0.99

0.08

1.4

130.05

132.57

pmol/l

0.05

1188

7969

Spinal stenosis

488

3553

1.01

0.08

1.4

179.72

183.23

pmol/l

0.03

472

3466

Radial styloid tenosynovitis [de Quervain]

775

1.03

0.08

1.5

86.94

125.30

pmol/l

1.12

762

Non-rheumatic valve diseases

427

3008

1.01

0.08

1.4

147.17

175.64

pmol/l

0.71

414

2935

Complications predominantly related to the puerperium

466

4713

0.99

0.08

1.4

1.5

67.33

115.02

pmol/l

8.50

456

4602

Scabies

332

1.06

0.08

1.3

1.4

54.51

131.93

pmol/l

1.36

323

Erysipelas

494

4210

1.01

0.08

1.5

1.4

173.52

146.94

pmol/l

0.42

480

4107

Obstructed labour due to maternal pelvic abnormality

253

2491

1.02

0.08

1.4

101.49

146.94

pmol/l

1.83

245

2436

Other and unspecified mononeuropathies of upper limb

244

1.07

0.08

1.7

1.4

78.88

204.25

pmol/l

1.42

239

Other and unspecified nonscarring hair loss

127

1.11

0.08

1.4

48.24

225.47

pmol/l

1.12

122

Pathological resorption of teeth

297

0.94

0.08

1.1

1.5

108.71

186.69

pmol/l

0.60

292

Other cataract

418

3142

0.99

0.08

1.5

200.39

177.08

pmol/l

0.18

402

3073

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.84

0.07

1.0

1.4

60.33

136.48

pmol/l

—

Anorexia

174

0.92

0.07

1.3

1.4

206.00

155.29

pmol/l

0.18

169

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.82

0.07

1.0

1.4

60.33

133.89

pmol/l

—

Mild mental retardation

174

0.92

0.07

1.7

1.4

84.50

151.46

pmol/l

0.49

168

Other deformity of hallux (acquired)

1.07

0.07

1.9

1.3

62.50

486.76

pmol/l

—

Other congenital malformations, not elsewhere classified

1.07

0.07

1.3

50.88

122.85

pmol/l

—

1.04

0.07

2.1

1.3

50.25

40.72

pmol/l

—

Bipolar affective disorders

213

2164

0.98

0.07

1.3

1.5

86.33

114.37

pmol/l

1.07

205

2117

Atopic dermatitis, strict definition

386

3816

0.99

0.07

1.4

67.74

101.03

pmol/l

2.75

376

3709

Assault by other specified means

0.83

0.07

1.1

1.3

74.57

110.34

pmol/l

—

Presence of other functional implants

603

4090

1.01

0.07

1.4

170.62

176.11

pmol/l

0.08

583

3994

Soft tissue disorders related to use, overuse and pressure

320

3161

1.01

0.07

1.5

1.4

97.61

158.36

pmol/l

3.87

312

3090

Human immunodeficiency virus [HIV] disease, including avohilmo

1.06

0.07

1.1

1.4

61.67

248.27

pmol/l

—

Unknown and unspecified causes of morbidity

600

0.97

0.07

1.4

100.98

185.99

pmol/l

1.38

587

Disorders of puberty

1.03

0.07

1.4

1.3

39.11

44.67

pmol/l

—

Respiratory tuberculosis

265

1.06

0.07

1.3

1.5

126.75

316.71

pmol/l

1.77

260

Respiratory tuberculosis, confirmed and not-confirmed

265

1.06

0.07

1.3

1.5

126.75

316.71

pmol/l

1.77

260

Otitis media, unspecified

102

917

1.02

0.07

1.4

1.5

55.95

136.49

pmol/l

3.02

889

Benign neoplasm: Skin of trunk

374

1.04

0.06

1.7

1.4

125.96

201.57

pmol/l

0.69

365

Condition for Implicit Sepsis (Organ dysfunction codes)

992

6825

1.01

0.06

1.5

1.4

176.53

134.99

pmol/l

1.81

962

6659

Polypectomy (DHB20)

325

1.05

0.06

1.4

81.50

227.51

pmol/l

1.89

319

Myeloid leukaemia

162

0.92

0.06

1.5

80.27

344.74

pmol/l

1.78

157

Other (not insulin) diabetes medications

1289

7522

1.01

0.06

1.4

184.44

124.92

pmol/l

1.64

1249

7352

Impingement syndrome of shoulder

237

2340

1.01

0.06

1.7

1.4

90.99

153.62

pmol/l

4.97

230

2292

Complications of internal orthopaedic prosthetic devices, implants and grafts

193

1903

1.01

0.06

1.5

1.4

300.34

212.84

pmol/l

0.41

188

1853

Unspecified lump in breast

258

2550

1.01

0.05

1.3

1.5

140.88

167.98

pmol/l

0.39

252

2485

Ulcerative proctitis

557

0.97

0.05

1.4

1.5

76.91

152.10

pmol/l

1.31

545

Diabetes medication

1368

8022

1.00

0.05

1.4

183.82

119.65

pmol/l

1.99

1325

7836

Disorders of ocular muscles, binocular movement, accommodation and refraction

599

5977

0.99

0.05

1.4

93.09

125.13

pmol/l

1.83

581

5822

IgA nephropathy (IgA glomerulonephritis)

141

0.92

0.05

1.6

1.4

143.53

176.64

pmol/l

0.15

136

Motorcycle rider injured in noncollision transport accidents

139

1.08

0.05

1.0

1.3

132.13

168.16

pmol/l

0.12

132

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

252

0.95

0.05

1.6

1.4

68.18

117.36

pmol/l

0.54

244

Postpartum haemorrhage

482

4006

0.99

0.05

1.4

53.88

94.49

pmol/l

7.33

467

3915

Placental disorders

151

0.92

0.05

1.1

1.4

45.71

138.68

pmol/l

0.72

145

Tobacco use

445

0.97

0.05

1.5

1.4

157.24

155.75

pmol/l

0.01

435

Pedal cyclist injured in transport accident

212

2094

1.01

0.05

1.5

1.4

65.74

144.03

pmol/l

6.95

203

2040

Allergic colitis

139

1.08

0.05

1.4

68.54

133.30

pmol/l

0.38

133

Intracranial injury

611

5653

1.01

0.05

1.4

118.68

146.20

pmol/l

1.31

586

5500

Preterm labour and delivery

450

4533

0.99

0.05

1.4

87.94

126.49

pmol/l

3.26

438

4436

Other strabismus

241

2427

0.99

0.05

1.5

1.4

91.63

131.37

pmol/l

1.09

234

2363

Viral agents as the cause of diseases classified to other chapters, including avohilmo

232

0.95

0.05

1.5

1.4

74.82

156.14

pmol/l

0.84

226

Unspecified privation

888

0.98

0.05

1.3

1.5

136.25

184.25

pmol/l

0.54

869

Emphysema

323

0.96

0.05

1.4

1.5

259.74

221.79

pmol/l

0.18

317

Other secondary coxarthrosis

258

1.05

0.04

1.5

1.6

165.52

274.61

pmol/l

0.46

252

Other salmonella infections

288

1.04

0.04

1.5

173.90

266.54

pmol/l

0.48

281

Other conjunctival vascular disorders and cysts

209

1.05

0.04

1.2

1.4

70.41

259.32

pmol/l

1.59

204

Other external causes of accidental injury

1090

5482

1.00

0.04

1.4

128.19

135.81

pmol/l

0.17

1063

5363

Vitreous haemorrhage

705

0.98

0.04

1.4

1.5

149.13

218.78

pmol/l

0.93

690

Disorders of lipoprotein metabolism and other lipidaemias

911

5560

1.00

0.04

1.5

1.4

224.68

140.54

pmol/l

2.03

882

5444

Biguanides

1227

7375

1.00

0.04

1.4

166.10

127.81

pmol/l

1.16

1189

7212

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

249

1.05

0.04

1.4

1.3

49.54

123.35

pmol/l

0.99

241

Maternal care for other known or suspected fetal problems

462

2878

1.01

0.04

1.4

66.08

64.87

pmol/l

0.05

448

2806

Anxious personality disorder

180

1.06

0.04

1.4

115.16

171.42

pmol/l

0.25

174

Papilloedema, unspecified

210

1.05

0.03

1.6

1.4

148.64

136.42

pmol/l

0.04

204

Chronic viral hepatitis

351

0.97

0.03

1.4

81.15

115.72

pmol/l

0.49

343

Tuberculosis, IBD comorbidity

389

1.03

0.03

1.3

1.5

129.61

256.56

pmol/l

1.53

380

Tuberculosis, wide

399

1.03

0.03

1.3

1.5

127.89

274.12

pmol/l

1.84

389

Nonsuppurative otitis media, including avohilmo

361

3139

0.99

0.03

1.5

84.26

112.39

pmol/l

1.35

348

3054

Other assisted single delivery

330

0.97

0.03

1.6

1.5

52.03

63.06

pmol/l

0.95

323

Congenital malformations of great arteries

116

0.93

0.03

1.2

1.3

97.09

102.85

pmol/l

0.04

110

Other disorders of ear

1110

7147

1.00

0.03

1.4

143.63

142.74

pmol/l

0.02

1078

6982

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

340

0.97

0.03

1.5

1.4

91.40

123.83

pmol/l

0.32

328

Suggestive for eosinophilic asthma

732

0.98

0.03

1.5

83.53

185.96

pmol/l

2.87

718

Disorders of optic nerve and visual pathways

983

0.99

0.03

1.6

1.5

130.97

163.40

pmol/l

0.37

962

Epiphora

239

0.96

0.02

1.9

1.5

99.07

324.94

pmol/l

2.00

234

Exclusion endpoint for clefts

158

0.95

0.02

1.4

1.3

130.62

155.60

pmol/l

0.08

153

Erosion of teeth , including avohilmo

316

3178

0.99

0.02

1.4

1.5

82.80

113.47

pmol/l

1.46

308

3096

Personality disorders, excluding more controls

308

3090

0.99

0.02

1.5

105.56

107.46

pmol/l

0.02

301

3007

Pedal cyclist injured in other and unspecified transport accidents

928

1.01

0.02

1.4

1.5

61.98

169.26

pmol/l

4.47

906

Dizziness and giddiness

945

7324

1.00

0.02

1.4

136.86

141.42

pmol/l

0.08

922

7150

Disorders of lens

677

4182

1.00

0.02

1.4

140.23

160.00

pmol/l

0.47

662

4088

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

117

0.93

0.02

1.6

1.4

196.96

65.73

pmol/l

0.51

110

Transport accidents

593

4951

1.00

0.02

1.5

1.4

79.59

135.39

pmol/l

5.35

567

4840

Alopecia areata

311

1.03

0.02

1.2

1.5

99.37

200.46

pmol/l

0.94

304

Non-selective monoamine reuptake inhibitors

445

4251

1.00

0.02

1.5

1.4

171.62

159.41

pmol/l

0.14

434

4162

Algoneurodystrophy

371

1.02

0.02

1.7

1.5

98.16

180.59

pmol/l

0.98

364

Disorders of refraction and accommodation

340

3402

1.00

0.02

1.4

93.28

122.19

pmol/l

1.16

328

3313

Superficial injury of abdomen, lower back and pelvis

146

1472

0.99

0.02

1.3

1.5

89.06

146.89

pmol/l

1.42

139

1431

Psoriasis (vulgaris), strict definition

218

0.96

0.02

1.5

1.4

109.00

226.23

pmol/l

0.81

212

Superficial injury of lower leg

305

3064

1.00

0.02

1.4

1.5

200.18

145.04

pmol/l

0.47

290

2978

Finngen Rheumatological endpoints

1242

7032

1.00

0.02

1.4

129.10

114.04

pmol/l

0.46

1207

6858

Conductive and sensorineural hearing loss

864

5719

1.00

0.02

1.4

147.67

158.14

pmol/l

0.23

838

5585

Caries in Clefts patients

103

1.07

0.02

1.7

1.3

60.82

90.64

pmol/l

0.35

Other papulosquamous disorders

103

1.07

0.02

1.4

92.64

226.66

pmol/l

0.61

Heart failure, strict

447

3094

1.00

0.02

1.5

318.03

204.74

pmol/l

1.24

436

3016

All-cause Heart Failure

440

3048

1.00

0.02

1.5

321.65

205.04

pmol/l

1.26

429

2971

Degeneration of macula and posterior pole

430

3328

1.00

0.01

1.4

1.5

202.44

209.81

pmol/l

0.08

408

3251

Other acute disseminated demyelination

123

1.06

0.01

1.4

64.52

98.03

pmol/l

0.48

118

Disorders of sclera, cornea, iris and ciliary body

628

6266

1.00

0.01

1.4

151.26

141.96

pmol/l

0.15

611

6116

Skin changes due to chronic exposure to nonionizing radiation

326

2940

1.00

0.01

1.5

207.16

224.83

pmol/l

0.24

315

2865

Coxarthrosis, primary

580

4802

1.00

0.01

1.4

169.02

185.67

pmol/l

0.26

565

4683

Amblyopia ex anopsia

317

0.98

0.01

1.4

60.65

227.44

pmol/l

2.22

307

Cleft palate

104

1.06

0.01

1.6

1.4

62.82

89.86

pmol/l

0.31

Unspecified acute lower respiratory infection

108

1073

1.01

0.00

1.5

1.4

133.61

160.44

pmol/l

0.25

103

1050

Pneumonia derived septicemia

206

0.97

0.00

1.3

1.4

453.00

284.60

pmol/l

0.26

201

Acute posthaemorrhagic anaemia

216

0.97

0.00

2.0

1.4

299.40

309.34

pmol/l

0.03

210

Anomalies of pupillary function

226

0.97

0.00

1.9

1.4

94.00

226.42

pmol/l

0.87

220

Immunodeficiency with predominantly antibody defects

256

0.98

0.00

1.6

1.4

110.28

137.42

pmol/l

0.27

251

Toxic effect of ethanol

264

1.02

0.00

1.3

1.4

60.67

154.48

pmol/l

1.26

256

Hereditary corneal dystrophies

316

0.98

0.00

1.2

1.5

71.14

248.09

pmol/l

3.07

309

Strabismus

286

2845

1.00

0.00

1.5

90.57

137.43

pmol/l

1.77

279

2768

353

3169

1.00

0.00

1.5

203.14

214.91

pmol/l

0.16

339

3090

Psoriasis vulgaris

157

1567

1.00

0.00

1.5

120.15

167.85

pmol/l

0.68

152

1528

Suppurative and necrotic conditions of lower respiratory tract

225

0.98

0.00

1.5

130.68

286.02

pmol/l

1.01

220

Varicella [chickenpox]

225

1.02

0.00

1.2

1.4

70.39

149.86

pmol/l

0.78

217

Maternal care for known or suspected abnormality of pelvic organs

489

3301

1.00

0.00

1.4

66.39

91.13

pmol/l

1.69

475

3224

Multiple myeloma and malignant plasma cell neoplasms

271

1.00

0.00

1.3

1.5

311.62

350.22

pmol/l

0.08

266

Septal defects

464

0.99

0.00

1.5

90.01

183.98

pmol/l

1.32

450

Tuberculosis, wide, including avohilmo

409

1.00

0.00

1.3

1.5

127.89

272.47

pmol/l

1.86

399

Benign neoplasm: Skin of upper limb, including shoulder

185

0.97

0.00

1.5

129.33

249.58

pmol/l

0.62

180

154

0.97

0.00

1.4

47.20

78.13

pmol/l

0.62

148

Ganglion

289

2885

1.00

0.00

1.4

115.03

124.51

pmol/l

0.16

282

2815

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

305

0.98

0.00

1.1

1.5

54.27

112.39

pmol/l

0.92

296

Intentional self-harm by unspecified means

123

0.98

0.00

1.3

63.08

87.51

pmol/l

0.35

118

Coxarthrosis

511

3294

1.00

0.00

1.4

158.43

162.65

pmol/l

0.05

503

3220

Other vitreous opacities

344

0.99

0.00

1.2

1.5

63.71

232.98

pmol/l

2.61

338

Disorders of puberty, all

102

0.98

0.00

1.4

1.3

39.60

45.26

pmol/l

—

Personal history of risk-factors, not elsewhere classified

132

0.98

0.00

1.5

1.3

58.47

96.04

pmol/l

0.63

127

Fracture of lower leg, including ankle

649

6366

1.00

0.00

1.4

135.53

149.98

pmol/l

0.40

625

6223

Blepharochalasis

341

3414

1.00

0.00

1.4

110.21

209.45

pmol/l

5.69

333

3333

Juvenile osteochondrosis

278

1.01

0.00

1.4

59.71

135.96

pmol/l

1.00

269

Migraine without aura, drug-induced

139

1.01

0.00

1.2

1.4

66.86

177.96

pmol/l

0.76

134

Retinal detachments and breaks

307

3073

1.00

0.00

1.4

1.5

137.76

191.45

pmol/l

1.50

301

3001

Other disorders of the musculoskeletal system and connective tissue

134

1339

1.00

0.00

1.5

149.99

174.57

pmol/l

0.26

129

1305

Congenital malformations of cardiac septa

486

1.00

0.00

1.5

89.05

177.40

pmol/l

1.29

471

Viral conjunctivitis

231

1.00

0.00

1.2

1.4

97.17

189.93

pmol/l

0.60

225

Other facial nerve disorders

265

0.98

0.00

1.4

54.85

196.54

pmol/l

2.05

259

Keratoconus

165

1.03

0.00

1.2

1.4

62.78

102.04

pmol/l

0.84

160

Other forms of systemic lupus erythematosus

125

1.04

0.00

1.5

1.4

72.38

195.78

pmol/l

0.76

120

Other specified congenital malformation syndromes affecting multiple systems

123

0.97

0.00

1.5

1.3

41.94

184.10

pmol/l

0.91

118

Taeniasis

0.00

0.0

1.2

—

93.17

—

Fracture of upper limb, level unspecified

0.00

0.0

1.0

—

76.80

—

Common variable immunodeficiency with autoantibodies to B- or T-cells

0.00

0.0

1.2

—

70.80

—

Brain mixed glioma, helper endpoint

0.00

0.0

1.7

—

55.66

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.0

1.6

—

57.51

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

1.1

—

54.13

—

Coccidioidomycosis, including avohilmo

0.00

0.0

2.0

—

84.33

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.1

—

47.89

—

Myiasis

0.00

0.0

1.3

—

69.43

—

Café au lait spots

0.00

0.0

2.0

—

51.00

—

Asphyxiation

0.00

0.0

1.2

—

51.50

—

Degeneration of iris and ciliary body

0.00

-0.00

0.0

1.5

—

46.93

—

Need for immunization against combinations of infectious diseases

0.00

-0.00

0.0

1.3

—

48.23

—

Brain mixed glioma

0.00

-0.00

0.0

1.5

—

45.93

—

Amputation of ankle

0.00

-0.00

0.0

1.1

—

87.29

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.3

—

56.43

—

Gastroenterology and urology devices associated with adverse incidents

0.00

-0.00

0.0

1.4

—

87.80

—

Alport

0.00

-0.00

0.0

1.3

—

51.78

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.1

—

61.20

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.4

—

77.11

—

Other specified air transport accidents

0.00

-0.00

0.0

1.2

—

86.20

—

Discharge of firework

0.00

-0.00

0.0

1.9

—

44.67

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

1.6

—

85.60

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.5

—

70.50

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.4

—

45.14

—

Accident to watercraft causing other injury

0.00

-0.00

0.0

1.1

—

66.13

—

Haemoglobinuria due to haemolysis from other external causes

0.00

-0.00

0.0

1.2

—

68.33

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.4

—

88.60

—

Disorders of purine and pyrimidine metabolism, other/unspecified

0.00

-0.00

0.0

2.4

—

74.92

—

Granuloma faciale [eosinophilic granuloma of skin]

0.00

-0.00

0.0

1.2

—

65.40

—

Pityriasis lichenoides et varioliformis acuta

0.00

-0.00

0.0

1.3

—

51.49

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.4

—

65.13

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

50.40

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.3

—

67.57

—

Hyperalimentation, other specified

0.00

-0.00

0.0

1.2

—

81.33

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.00

-0.00

0.0

1.1

—

73.00

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.2

—

51.00

—

Disorders of aromatic amino-acid metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

45.00

—

Disorders of copper metabolism

0.00

-0.00

0.0

1.2

—

54.20

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.5

—

146.25

—

Crushing injury of head

0.00

-0.00

0.0

1.3

—

65.78

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.2

—

57.50

—

Other transepidermal elimination disorders

0.00

-0.00

0.0

1.2

—

67.40

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.3

—

79.23

—

Unspecified hairloss

0.00

-0.00

0.0

1.5

—

75.17

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.2

—

42.00

—

Mental and behavioural disorders due to cocaine

0.00

-0.00

0.0

1.5

—

45.83

—

Abscess of mediastinum

0.00

-0.00

0.0

1.6

—

80.44

—

Other chronic figurate erythema

0.00

-0.00

0.0

1.0

—

66.40

—

Polyglandular dysfunction, other/unspecified

0.00

-0.00

0.0

1.4

—

46.80

—

Classical phenylketonuria

0.00

-0.00

0.0

1.6

—

70.51

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

1.2

—

50.17

—

Human immunodeficiency virus [HIV] disease

1.01

-0.00

1.1

1.4

57.50

126.87

pmol/l

—

Other rickettsioses

0.00

-0.00

0.0

1.3

—

78.17

—

Neuropathy in association with hereditary ataxia

0.00

-0.00

0.0

1.2

—

108.60

—

Palsy of conjugate gaze

0.00

-0.00

0.0

1.6

—

54.43

—

Nocardiosis, including avohilmo

0.00

-0.00

0.0

1.2

—

61.90

—

Habit and impulse disorders

110

1.00

-0.00

1.7

1.4

60.73

101.76

pmol/l

0.55

105

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

2.0

—

44.75

—

Other migraine, drug-induced

0.00

-0.00

0.0

1.4

—

62.40

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

50.33

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.0

—

61.33

—

Other rickettsioses, including avohilmo

0.00

-0.00

0.0

1.3

—

78.17

—

Bacterial meningoencephalitis and meningomyelitis

0.00

-0.00

0.0

1.2

—

59.78

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.4

—

65.63

—

Bartonellosis, including avohilmo

0.00

-0.00

0.0

1.2

—

77.00

—

Echinococcosis

0.00

-0.00

0.0

1.2

—

71.80

—

Otitis media in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

59.29

—

Echinococcosis, including avohilmo

0.00

-0.00

0.0

1.2

—

71.80

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.4

—

44.37

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

674.17

—

Polyp of middle ear

0.00

-0.00

0.0

1.6

—

88.60

—

Choroidal degeneration

0.00

-0.00

0.0

1.6

—

97.60

—

Anencephaly and similar malformations

0.00

-0.00

0.0

1.3

—

562.71

—

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

50.80

—

Noonan syndrome

0.00

-0.00

0.0

1.3

—

41.45

—

Nocardiosis

0.00

-0.00

0.0

1.2

—

61.90

—

Vertiginous syndromes in diseases classified elsewhere

0.00

-0.00

0.0

1.1

—

96.20

—

Coccidioidomycosis

0.00

-0.00

0.0

2.2

—

93.40

—

Fusion of the labia

0.00

-0.00

0.0

1.0

—

50.00

—

Interstitial myositis

0.00

-0.00

0.0

1.3

—

86.71

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Human epididymis protein 4 [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS